11/12/2024 | Press release | Distributed by Public on 11/12/2024 16:16
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-258149
PROSPECTUS SUPPLEMENT NO. 6
(to prospectus dated May 22, 2024)
THE BEACHBODY COMPANY, INC.
4,866,405 SHARES OF COMMON STOCK
5,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK
306,667 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS
This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated May 22, 2024 (the "Prospectus"), related to (i) the offer and sale, from time to time, by the selling stockholders identified in the Prospectus, or their permitted transferees, of (a) an aggregate of 4,866,405 shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of The Beachbody Company, Inc., a Delaware corporation ("we," "us," "our" and similar terms), and (b) 5,333,333 warrants to purchase Class A Common Stock, every 50 warrants exercisable for one share of Class A Common Stock at an exercise price of $575.00 per share (the "private placement warrants") and (ii) the issuance by us of up to 306,667 shares of Class A Common Stock upon the exercise of outstanding public warrants (the "public warrants") and private placement warrants (collectively, the "warrants"), with the information contained in our Quarterly Report on Form 10-Q, for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission ("SEC") on November 12, 2024 (the "Information"). Accordingly, we have attached the Information to this prospectus supplement.
This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
Our shares of Class A Common Stock are listed on The New York Stock Exchange under the symbol "BODI." On November 11, 2024, the closing sale price per share of our Class A Common Stock was $6.66.
Investing in our securities involves risks that are described in the "Risk Factors" section beginning on page 11 of the Prospectus. Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is November 12, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2024
or
☐ |
TRANSITION REPORT PURSUANT TO Section 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-39735
The Beachbody Company, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
85-3222090 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
400 Continental Blvd, Suite 400 El Segundo, California |
90245 |
(Address of principal executive offices) |
(Zip Code) |
(310) 883-9000
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Class A Common Stock, par value $0.0001 per share |
BODI |
The New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ☐ |
Accelerated Filer ☐ |
Non-Accelerated Filer ☒ |
Smaller Reporting Company ☒ |
Emerging Growth Company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
There were 4,194,596 shares of the registrant's Class A Common Stock, par value $0.0001 per share, and 2,729,003 shares of the registrant's Class X Common Stock, par value $0.0001 per share, outstanding as of November 5, 2024.
Table of Contents
Part I. |
Financial Information |
3 |
Item 1. |
Financial Statements |
3 |
Condensed Consolidated Balance Sheets |
3 |
|
Unaudited Condensed Consolidated Statements of Operations |
4 |
|
Unaudited Condensed Consolidated Statements of Comprehensive Loss |
5 |
|
Unaudited Condensed Consolidated Statements of Stockholders' Equity |
6 |
|
Unaudited Condensed Consolidated Statements of Cash Flows |
7 |
|
Notes to Unaudited Condensed Consolidated Financial Statements |
8 |
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Operations |
28 |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
43 |
Item 4. |
Controls and Procedures |
43 |
Part II. |
Other Information |
44 |
Item 1. |
Legal Proceedings |
44 |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
45 |
Item 3. |
Defaults Upon Senior Securities |
45 |
Item 4. |
Mine Safety Disclosures |
45 |
Item 5. |
Other Information |
45 |
Item 6. |
Exhibits |
47 |
Signatures |
48 |
PART I-FINANCIAL INFORMATION
Item 1. Financial Statements.
The Beachbody Company, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
September 30, |
December 31, |
|||||||
2024 |
2023 |
|||||||
(unaudited) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents (restricted cash of $0.1 million at September 30, 2024 and December 31, 2023, respectively) |
$ |
32,313 |
$ |
33,409 |
||||
Restricted short-term investments |
4,250 |
4,250 |
||||||
Inventory |
18,008 |
24,976 |
||||||
Prepaid expenses |
5,880 |
10,715 |
||||||
Other current assets |
34,800 |
45,923 |
||||||
Total current assets |
95,251 |
119,273 |
||||||
Property and equipment, net |
24,905 |
45,055 |
||||||
Content assets, net |
14,498 |
21,359 |
||||||
Goodwill |
85,166 |
85,166 |
||||||
Right-of-use assets, net |
2,794 |
3,063 |
||||||
Other assets |
2,851 |
2,923 |
||||||
Total assets |
$ |
225,465 |
$ |
276,839 |
||||
Liabilities and Stockholders' Equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ |
7,110 |
$ |
10,659 |
||||
Accrued expenses |
37,928 |
42,147 |
||||||
Deferred revenue |
88,784 |
97,169 |
||||||
Current portion of lease liabilities |
1,096 |
1,835 |
||||||
Current portion of Term Loan |
11,704 |
8,068 |
||||||
Other current liabilities |
1,995 |
5,325 |
||||||
Total current liabilities |
148,617 |
165,203 |
||||||
Term Loan |
10,019 |
21,491 |
||||||
Long-term lease liabilities, net |
1,848 |
1,425 |
||||||
Deferred tax liabilities |
- |
10 |
||||||
Other liabilities |
6,606 |
5,950 |
||||||
Total liabilities |
167,090 |
194,079 |
||||||
Stockholders' equity: |
||||||||
Preferred stock, $0.0001 par value; 100,000,000 shares |
- |
- |
||||||
Common stock, $0.0001 par value, 1,900,000,000 shares |
||||||||
Class A: 4,187,168 and 3,978,356 shares issued and |
1 |
1 |
||||||
Class X: 2,729,003 shares issued and outstanding |
1 |
1 |
||||||
Class C: no shares issued and outstanding at |
- |
- |
||||||
Additional paid-in capital |
667,300 |
654,657 |
||||||
Accumulated deficit |
(608,960 |
) |
(571,876 |
) |
||||
Accumulated other comprehensive income (loss) |
33 |
(23 |
) |
|||||
Total stockholders' equity |
58,375 |
82,760 |
||||||
Total liabilities and stockholders' equity |
$ |
225,465 |
$ |
276,839 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The Beachbody Company, Inc.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except per share data)
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenue: |
||||||||||||||||
Digital |
$ |
53,702 |
$ |
64,339 |
$ |
173,979 |
$ |
194,326 |
||||||||
Nutrition and other |
47,416 |
58,981 |
153,029 |
197,729 |
||||||||||||
Connected fitness |
1,075 |
4,930 |
5,414 |
16,044 |
||||||||||||
Total revenue |
102,193 |
128,250 |
332,422 |
408,099 |
||||||||||||
Cost of revenue: |
||||||||||||||||
Digital |
10,451 |
16,429 |
34,789 |
47,732 |
||||||||||||
Nutrition and other |
19,653 |
26,699 |
61,558 |
84,940 |
||||||||||||
Connected fitness |
3,278 |
10,091 |
9,606 |
26,312 |
||||||||||||
Total cost of revenue |
33,382 |
53,219 |
105,953 |
158,984 |
||||||||||||
Gross profit |
68,811 |
75,031 |
226,469 |
249,115 |
||||||||||||
Operating expenses: |
||||||||||||||||
Selling and marketing |
45,592 |
69,127 |
161,161 |
222,195 |
||||||||||||
Enterprise technology and development |
19,382 |
18,879 |
54,261 |
56,625 |
||||||||||||
General and administrative |
11,760 |
14,759 |
37,631 |
44,362 |
||||||||||||
Restructuring |
5,087 |
1,270 |
6,731 |
6,550 |
||||||||||||
Total operating expenses |
81,821 |
104,035 |
259,784 |
329,732 |
||||||||||||
Operating loss |
(13,010 |
) |
(29,004 |
) |
(33,315 |
) |
(80,617 |
) |
||||||||
Other income (expense): |
||||||||||||||||
Loss on partial debt extinguishment |
- |
(3,168 |
) |
(1,928 |
) |
(3,168 |
) |
|||||||||
Change in fair value of warrant liabilities |
1,410 |
1,072 |
1,333 |
1,504 |
||||||||||||
Interest expense |
(1,646 |
) |
(2,074 |
) |
(5,173 |
) |
(6,773 |
) |
||||||||
Other income, net |
1,358 |
571 |
2,243 |
1,551 |
||||||||||||
Loss before income taxes |
(11,888 |
) |
(32,603 |
) |
(36,840 |
) |
(87,503 |
) |
||||||||
Income tax provision |
(115 |
) |
(63 |
) |
(244 |
) |
(99 |
) |
||||||||
Net loss |
$ |
(12,003 |
) |
$ |
(32,666 |
) |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
||||
Net loss per common share, basic and diluted |
$ |
(1.75 |
) |
$ |
(5.29 |
) |
$ |
(5.45 |
) |
$ |
(14.09 |
) |
||||
Weighted-average common shares outstanding, basic and diluted |
6,841 |
6,179 |
6,805 |
6,216 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The Beachbody Company, Inc.
Unaudited Condensed Consolidated Statements of Comprehensive Loss
(in thousands)
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Net loss |
$ |
(12,003 |
) |
$ |
(32,666 |
) |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
||||
Other comprehensive income (loss): |
||||||||||||||||
Change in fair value of derivative financial instruments, net of tax |
- |
31 |
- |
(358 |
) |
|||||||||||
Reclassification of gains (losses) on derivative financial instruments |
- |
157 |
80 |
131 |
||||||||||||
Foreign currency translation adjustment |
22 |
(50 |
) |
(24 |
) |
(5 |
) |
|||||||||
Total other comprehensive income (loss) |
22 |
138 |
56 |
(232 |
) |
|||||||||||
Total comprehensive loss |
$ |
(11,981 |
) |
$ |
(32,528 |
) |
$ |
(37,028 |
) |
$ |
(87,834 |
) |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The Beachbody Company, Inc.
Unaudited Condensed Consolidated Statements of Stockholders' Equity
(in thousands)
Accumulated |
||||||||||||||||||||||||
Additional |
Other |
Total |
||||||||||||||||||||||
Common Stock |
Paid-In |
Accumulated |
Comprehensive |
Stockholders' |
||||||||||||||||||||
Shares |
Amount |
Capital |
Deficit |
Income (Loss) |
Equity |
|||||||||||||||||||
Balances at December 31, 2022 |
6,243 |
$ |
2 |
$ |
630,738 |
$ |
(419,235 |
) |
$ |
37 |
$ |
211,542 |
||||||||||||
Net loss |
- |
- |
- |
(29,188 |
) |
- |
(29,188 |
) |
||||||||||||||||
Other comprehensive loss |
- |
- |
- |
- |
(224 |
) |
(224 |
) |
||||||||||||||||
Equity-based compensation |
195 |
- |
9,555 |
- |
- |
9,555 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
(73 |
) |
- |
(2,128 |
) |
- |
- |
(2,128 |
) |
|||||||||||||||
Balances at March 31, 2023 |
6,365 |
$ |
2 |
$ |
638,165 |
$ |
(448,423 |
) |
$ |
(187 |
) |
$ |
189,557 |
|||||||||||
Net loss |
- |
- |
- |
(25,748 |
) |
- |
(25,748 |
) |
||||||||||||||||
Other comprehensive loss |
- |
- |
- |
- |
(146 |
) |
(146 |
) |
||||||||||||||||
Equity-based compensation |
27 |
- |
3,161 |
- |
- |
3,161 |
||||||||||||||||||
Forfeiture of shares per the Forfeiture Agreement |
(160 |
) |
- |
- |
- |
- |
- |
|||||||||||||||||
Issuance of shares due to Employee Stock Purchase Plan |
20 |
- |
384 |
- |
- |
384 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
- |
- |
(31 |
) |
- |
- |
(31 |
) |
||||||||||||||||
Balances at June 30, 2023 |
6,252 |
$ |
2 |
$ |
641,679 |
$ |
(474,171 |
) |
$ |
(333 |
) |
$ |
167,177 |
|||||||||||
Net loss |
- |
- |
- |
(32,666 |
) |
- |
(32,666 |
) |
||||||||||||||||
Other comprehensive income |
- |
- |
- |
- |
138 |
138 |
||||||||||||||||||
Equity-based compensation |
3 |
- |
6,436 |
- |
- |
6,436 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
(1 |
) |
- |
(14 |
) |
- |
- |
(14 |
) |
|||||||||||||||
Balances at September 30, 2023 |
6,254 |
$ |
2 |
$ |
648,101 |
$ |
(506,837 |
) |
$ |
(195 |
) |
$ |
141,071 |
|||||||||||
Accumulated |
||||||||||||||||||||||||
Additional |
Other |
Total |
||||||||||||||||||||||
Common Stock |
Paid-In |
Accumulated |
Comprehensive |
Stockholders' |
||||||||||||||||||||
Shares |
Amount |
Capital |
Deficit |
Income (Loss) |
Equity |
|||||||||||||||||||
Balances at December 31, 2023 |
6,707 |
$ |
2 |
$ |
654,657 |
$ |
(571,876 |
) |
$ |
(23 |
) |
$ |
82,760 |
|||||||||||
Net loss |
- |
- |
- |
(14,216 |
) |
- |
(14,216 |
) |
||||||||||||||||
Other comprehensive income |
- |
- |
- |
- |
38 |
38 |
||||||||||||||||||
Equity-based compensation |
61 |
- |
4,365 |
- |
- |
4,365 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
(24 |
) |
- |
(206 |
) |
- |
- |
(206 |
) |
|||||||||||||||
Pre-funded warrants exercised |
123 |
- |
- |
- |
- |
- |
||||||||||||||||||
Balances at March 31, 2024 |
6,867 |
$ |
2 |
$ |
658,816 |
$ |
(586,092 |
) |
$ |
15 |
$ |
72,741 |
||||||||||||
Net loss |
- |
- |
- |
(10,865 |
) |
- |
(10,865 |
) |
||||||||||||||||
Other comprehensive loss |
- |
- |
- |
- |
(4 |
) |
(4 |
) |
||||||||||||||||
Equity-based compensation |
24 |
- |
4,739 |
- |
- |
4,739 |
||||||||||||||||||
Issuance of shares due to Employee Stock Purchase Plan |
24 |
- |
165 |
- |
- |
165 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
- |
- |
(17 |
) |
- |
- |
(17 |
) |
||||||||||||||||
Balances at June 30, 2024 |
6,915 |
$ |
2 |
$ |
663,703 |
$ |
(596,957 |
) |
$ |
11 |
$ |
66,759 |
||||||||||||
Net loss |
- |
- |
- |
(12,003 |
) |
- |
(12,003 |
) |
||||||||||||||||
Other comprehensive income |
- |
- |
- |
- |
22 |
22 |
||||||||||||||||||
Equity-based compensation |
2 |
- |
3,591 |
- |
- |
3,591 |
||||||||||||||||||
Tax withholdings on vesting of restricted stock |
(1 |
) |
- |
6 |
- |
- |
6 |
|||||||||||||||||
Balances at September 30, 2024 |
6,916 |
$ |
2 |
$ |
667,300 |
$ |
(608,960 |
) |
$ |
33 |
$ |
58,375 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The Beachbody Company, Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
(in thousands)
Nine months ended September 30, |
||||||||
2024 |
2023 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization expense |
18,756 |
31,395 |
||||||
Amortization of content assets |
12,525 |
16,487 |
||||||
Provision for inventory and inventory purchase commitments |
2,748 |
9,370 |
||||||
Realized (gains) losses on hedging derivative financial instruments |
64 |
131 |
||||||
Change in fair value of warrant liabilities |
(1,333 |
) |
(1,504 |
) |
||||
Equity-based compensation |
12,695 |
19,152 |
||||||
Deferred income taxes |
2 |
(166 |
) |
|||||
Amortization of debt issuance costs |
1,751 |
1,288 |
||||||
Paid-in-kind interest expense |
633 |
1,042 |
||||||
Loss on partial debt extinguishment |
1,928 |
2,418 |
||||||
Change in lease assets |
269 |
- |
||||||
Gain on sale of property and equipment |
(784 |
) |
- |
|||||
Changes in operating assets and liabilities: |
||||||||
Inventory |
4,162 |
11,884 |
||||||
Content assets |
(5,664 |
) |
(8,201 |
) |
||||
Prepaid expenses |
4,835 |
4,302 |
||||||
Other assets |
11,212 |
(4,531 |
) |
|||||
Accounts payable |
(3,319 |
) |
(1,471 |
) |
||||
Accrued expenses |
(3,824 |
) |
(15,809 |
) |
||||
Deferred revenue |
(6,290 |
) |
6,995 |
|||||
Other liabilities |
(3,991 |
) |
237 |
|||||
Net cash provided by (used in) operating activities |
9,291 |
(14,583 |
) |
|||||
Cash flows from investing activities: |
||||||||
Purchase of property and equipment |
(3,974 |
) |
(5,499 |
) |
||||
Investment in restricted short-term investments |
- |
(4,250 |
) |
|||||
Proceeds from sale of property and equipment |
5,600 |
- |
||||||
Net cash provided by (used in) investing activities |
1,626 |
(9,749 |
) |
|||||
Cash flows from financing activities: |
||||||||
Debt repayments |
(11,758 |
) |
(15,938 |
) |
||||
Proceeds from issuance of common shares in the Employee Stock Purchase Plan |
165 |
384 |
||||||
Tax withholding payments for vesting of restricted stock |
(217 |
) |
(2,173 |
) |
||||
Net cash used in financing activities |
(11,810 |
) |
(17,727 |
) |
||||
Effect of exchange rates on cash, cash equivalents, and restricted cash |
(203 |
) |
159 |
|||||
Net decrease in cash, cash equivalents, and restricted cash |
(1,096 |
) |
(41,900 |
) |
||||
Cash, cash equivalents and restricted cash, beginning of period |
33,409 |
80,091 |
||||||
Cash, cash equivalents, and restricted cash, end of period |
$ |
32,313 |
$ |
38,191 |
||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid during the period for interest |
$ |
2,758 |
$ |
4,177 |
||||
Cash paid (received) during the period for income taxes, net |
225 |
(10 |
) |
|||||
Supplemental disclosure of noncash investing activities: |
||||||||
Property and equipment acquired but not yet paid for |
$ |
265 |
$ |
267 |
||||
Supplemental disclosure of noncash financing activities: |
||||||||
Change in fair value of Term Loan warrants due to amended exercise price |
$ |
141 |
$ |
802 |
||||
Paid-in-kind fee recorded as incremental debt issuance cost |
566 |
488 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The Beachbody Company, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
1. Description of Business and Summary of Significant Accounting Policies
Business
The Beachbody Company, Inc. ("BODi" or the "Company") is a leading fitness and nutrition company and the creator of some of the world's most popular fitness programs. The Company's fitness programs are available for streaming through subscription and/or digital program purchases on the BODi digital platform, accessible through a web browser, iOS devices, Android Devices and Roku. During the three months ended March 31, 2023, the Company launched an improved BODi experience and began migrating all BOD-only members to BODi on their renewal dates. BODi offers nutritional products such as Shakeology nutrition shakes, Beachbody Performance supplements and BEACHBAR snack bars, which have been designed and clinically tested to help customers achieve their goals. The Company's revenue has historically been generated primarily through a network of micro-influencers ("Partners"), social media marketing channels, and direct response advertising. On September 30, 2024, the Company announced strategic initiatives to transition its network business from a Multi-Level Marketing ("MLM") model to a single level affiliate model (the "Pivot"). See Note 12, Restructuring, for more information on the Pivot.
Basis of Presentation and Principles of Consolidation
The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information as determined by the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and pursuant to the regulations of the U.S. Securities and Exchange Commission ("SEC").
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates in our condensed consolidated financial statements include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Actual results could differ from those estimates. We periodically review estimates and assumptions and we reflect the effects of changes, if any, in the unaudited condensed consolidated financial statements in the period that they are determined.
The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary for the fair statement of the Company's financial position, results of operations, and cash flows. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated in consolidation. The financial data and other financial information disclosed in the notes to these unaudited condensed consolidated financial statements are also unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. Interim results are not necessarily indicative of the results that may be expected for the full fiscal year or any other period.
Summary of Changes in Significant Accounting Estimates
Goodwill and Long-Lived Assets, Net
Interim Impairment Test
Goodwill represents the excess of the fair value of the consideration transferred in a business combination over the fair value of the underlying identifiable assets and liabilities acquired. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually as of December 31 and between annual tests if an event or change in circumstances occurs that would more likely than not reduce the fair value of a reporting unit ("RU") below its carrying value or indicate that it is more likely than not that the indefinite-lived asset is impaired. As of September 30, 2024, the Company has no indefinite-lived intangible assets.
Due to the sustained decline in the Company's market capitalization in the three and nine months ended September 30, 2024 and the impact of the Pivot, which was approved by the Board of Directors (the "Board") of the Company in late September 2024, the Company performed an interim test for impairment of its goodwill as of September 30, 2024. In performing the interim impairment test for goodwill, the Company elected to bypass the optional qualitative test and proceeded to perform a quantitative test by comparing the carrying value of its RU to its estimated fair value. The Company previously tested its RU for impairment as of December 31, 2023. The results of the Company's interim test for impairment at September 30, 2024 concluded that the fair value of its RU exceeded its carrying value, resulting in no impairment.
Long-Lived Assets
Management reviews long-lived assets (including property and equipment, content assets, and definite-lived intangible assets) for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Recoverability of assets is determined by comparing their carrying value to the forecasted undiscounted cash flows associated with the assets. If the evaluation of the forecasted cash flows indicates that the carrying value of the assets is not recoverable, the assets are written down to their fair value. The Company performed a test for recoverability as of September 30, 2024 and concluded that the carrying value of its long-lived assets were recoverable.
Reverse Stock Split
On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split. All applicable share data, per share amounts and related information in the unaudited condensed consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the 1-for-50 reverse stock split. See Note 10, Stockholders' Equity, for additional information regarding the reverse stock split.
Recently Adopted Accounting Pronouncements
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to apply ASC 606 to recognize and measure contract assets and liabilities from contracts with customers acquired in a business combination on the acquisition date rather than the general guidance in ASC 805. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.
In September 2022, the FASB issued ASU 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50) - Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures, to improve disclosures about a public entity's reportable segments through enhanced disclosures about significant segment expenses. The guidance in this update will be effective for public companies for annual periods beginning after December 15, 2023 and interim periods for years beginning after December 15, 2024. The Company is evaluating the potential impact of adopting this guidance on its unaudited condensed consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, to improve disclosures about a company's income taxes paid and the effective rate reconciliation table. The guidance in this update will be effective for public companies for annual periods beginning after December 15, 2024 and interim periods for years beginning after December 15, 2025. The Company is evaluating the potential impact of adopting this guidance on its unaudited condensed consolidated financial statements.
2. Revenue
The Company's revenue disaggregated by geographic region is as follows (in thousands):
Three months ended September 30, |
||||||||
2024 |
2023 |
|||||||
Geographic region: |
||||||||
United States |
$ |
92,317 |
$ |
114,736 |
||||
Rest of world1 |
9,876 |
13,514 |
||||||
Total revenue |
$ |
102,193 |
$ |
128,250 |
Nine months ended September 30, |
||||||||
2024 |
2023 |
|||||||
Geographic region: |
||||||||
United States |
$ |
298,490 |
$ |
366,680 |
||||
Rest of world1 |
33,932 |
41,419 |
||||||
Total revenue |
$ |
332,422 |
$ |
408,099 |
(1) Consists of Canada, United Kingdom, and France. Other than the United States, no single country accounted for more than 10% of total revenue during the three and nine months ended September 30, 2024 and 2023.
The Company determined that, in addition to the preceding table, the disaggregation of revenue by revenue type as presented in the unaudited condensed consolidated statements of operations achieves the disclosure requirement to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.
Deferred Revenue
Deferred revenue is recorded for nonrefundable cash payments received for the Company's performance obligation to transfer, or stand ready to transfer, goods or services in the future. Deferred revenue consists of subscription fees billed that have not been recognized and physical products sold that have not yet been delivered. The Company expects to recognize approximately 96% of the remaining performance obligations as revenue in the next 12 months, and the remainder thereafter. During the three and nine months ended September 30, 2024, the Company recognized $13.5 million and $88.9 million, respectively, of revenue that was included in the deferred revenue balance as of December 31, 2023. During the three and nine months ended September 30, 2023, the Company recognized $13.0 million and $90.9 million, respectively, of revenue that was included in the deferred revenue balance as of December 31, 2022.
3. Fair Value Measurements
The Company's financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
September 30, 2024 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets |
||||||||||||
Restricted short-term investments |
$ |
- |
$ |
4,250 |
$ |
- |
||||||
Total assets |
$ |
- |
$ |
4,250 |
$ |
- |
||||||
Liabilities |
||||||||||||
Public Warrants |
$ |
- |
$ |
- |
$ |
- |
||||||
Private Placement Warrants |
- |
- |
- |
|||||||||
Term Loan Warrants |
- |
- |
315 |
|||||||||
Common Stock Warrants |
- |
- |
1,618 |
|||||||||
Total liabilities |
$ |
- |
$ |
- |
$ |
1,933 |
||||||
December 31, 2023 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets |
||||||||||||
Restricted short-term investments |
$ |
- |
$ |
4,250 |
$ |
- |
||||||
Total assets |
$ |
- |
$ |
4,250 |
$ |
- |
||||||
Liabilities |
||||||||||||
Public Warrants |
$ |
- |
$ |
- |
$ |
17 |
||||||
Private Placement Warrants |
- |
- |
9 |
|||||||||
Term Loan Warrants |
- |
- |
392 |
|||||||||
Common Stock Warrants |
- |
- |
2,707 |
|||||||||
Total liabilities |
$ |
- |
$ |
- |
$ |
3,125 |
Fair values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate the recorded value due to the short period of time to maturity. Restricted short-term investments of $4.3 million at September 30, 2024 consist of a one-year certificate of deposit ("CD") that matures on July 26, 2025 with an interest rate of 4.4%. The Company's Private Placement Warrants (as defined below), Term Loan Warrants (as defined below) and Common Stock Warrants (as defined below), and the Company's Public Warrants (as defined below) after they ceased trading on an active market, are classified within Level 3 of the fair value hierarchy because their fair values are based on significant inputs that are unobservable in the market.
Private Placement Warrants
The Company determined the fair value of the outstanding warrants for the purchase of 106,667 shares of the Company's Class A common stock at an exercise price of $575.00 per share (the "Private Placement Warrants") using a Black-Scholes option-pricing model and the quoted price of the Company's Class A common stock. Volatility was based on the implied volatility derived from the Company's historical volatility. The expected life was based on the remaining contractual term of the Private Placement Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Private Placement Warrants expected life. The significant unobservable input used in the fair value measurement of the Private Placement Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively.
The following table presents significant assumptions utilized in the valuation of the Private Placement Warrants on September 30, 2024 and December 31, 2023:
September 30, 2024 |
December 31, 2023 |
|||||||
Risk-free rate |
3.7 |
% |
4.1 |
% |
||||
Dividend yield rate |
- |
- |
||||||
Volatility |
93.2 |
% |
97.6 |
% |
||||
Contractual term (in years) |
1.73 |
2.48 |
||||||
Exercise price |
$ |
575.00 |
$ |
575.00 |
The following table presents changes in the fair value of the Private Placement Warrants for the three and nine months ended September 30, 2024 and 2023 (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Balance, beginning of period |
$ |
2 |
$ |
53 |
$ |
9 |
$ |
107 |
||||||||
Change in fair value |
(2 |
) |
(47 |
) |
(9 |
) |
(101 |
) |
||||||||
Balance, end of period |
$ |
- |
$ |
6 |
$ |
- |
$ |
6 |
For the three and nine months ended September 30, 2024 and 2023, the change in the fair value of the Private Placement Warrants resulted from the change in price of the Company's Class A common stock, remaining contractual term and risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
Public Warrants
The Company determined the fair value of the outstanding warrants for the purchase of 200,000 shares of the Company's Class A common stock at an exercise price of $575.00 per share (the "Public Warrants"), which traded in active markets until November 24, 2023, based on quoted market prices during the period it was traded in active markets. The Company determined the fair value of the Public Warrants after November 24, 2023 using a Black-Scholes option-pricing model and the quoted price of the Company's Class A common stock. Volatility was based on the implied volatility derived from the Company's historical volatility. The expected life was based on the remaining contractual term of the Public Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Public Warrants expected life. The significant unobservable input used in the fair value measurement of the Public Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. The following table presents significant assumptions utilized in the valuation of the Public Warrants on September 30, 2024 and December 31, 2023:
September 30, 2024 |
December 31, 2023 |
|||||||
Risk-free rate |
3.7 |
% |
4.1 |
% |
||||
Dividend yield rate |
- |
- |
||||||
Volatility |
93.2 |
% |
97.6 |
% |
||||
Contractual term (in years) |
1.73 |
2.48 |
||||||
Exercise price |
$ |
575.00 |
$ |
575.00 |
The following table presents changes in the fair value of the Public Warrants for the three and nine months ended September 30, 2024 and 2023 (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Balance, beginning of period |
$ |
4 |
$ |
461 |
$ |
17 |
$ |
415 |
||||||||
Change in fair value |
(4 |
) |
(271 |
) |
(17 |
) |
(225 |
) |
||||||||
Balance, end of period |
$ |
- |
$ |
190 |
$ |
- |
$ |
190 |
For the three and nine months ended September 30, 2024 the change in the fair value of the Public Warrants resulted from the change in price of the Company's Class A common stock, remaining contractual term, and risk-free rate. For the three and nine months ended September 30, 2023, the change in the fair value of the Public Warrants resulted from the change in the price of the Public Warrants as traded on an active market. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
Term Loan Warrants
The Company determined the fair value of the Term Loan Warrants (as defined below) using a Black-Scholes option-pricing model and the quoted price of the Company's Class A common stock. Volatility was based on the implied volatility derived primarily from the average of the actual market activity of the Company's peer group and the Company's historical volatility. The expected life was based on the remaining contractual term of the Term Loan Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Term Loan Warrants expected life. The significant unobservable input used in the fair value measurement of the Term Loan Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. See Note 9, Debt, and Note 15, Subsequent Events, for additional information regarding the Term Loan Warrants.
The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at September 30, 2024 and December 31, 2023:
September 30, 2024 |
December 31, 2023 |
|||||||
Risk-free rate |
3.6 |
% |
3.8 |
% |
||||
Dividend yield rate |
- |
- |
||||||
Volatility |
80.1 |
% |
74.5 |
% |
||||
Contractual term (in years) |
4.85 |
5.60 |
||||||
Exercise price |
$ |
9.16 |
$ |
20.50 |
The following table presents changes in the fair value of the Term Loan Warrants for the three and nine months ended September 30, 2024 and 2023 (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Balance, beginning of period |
$ |
537 |
$ |
802 |
$ |
392 |
$ |
1,226 |
||||||||
Amended in connection with Second Amendment |
- |
802 |
- |
802 |
||||||||||||
Amended in connection with Fifth Amendment |
- |
- |
141 |
- |
||||||||||||
Change in fair value |
(222 |
) |
(755 |
) |
(218 |
) |
(1,179 |
) |
||||||||
Balance, end of period |
$ |
315 |
$ |
849 |
$ |
315 |
$ |
849 |
For the three and nine months ended September 30, 2024, the change in the balance of the Term Loan Warrants was due to the Warrant Second Amendment (as defined below) of the Term Loan Warrants, which reduced the exercise price from $20.50 per share to $9.16
per share which resulted in an increase in the fair value of the Term Loan Warrants of $0.1 million as of the Fifth Amendment Effective Date (as defined below) and the change in the fair value of the Term Loan Warrants resulting from the change in price of the Company's Class A common stock, the remaining contractual term and the risk-free rate. For the three and nine months ended September 30, 2023, the change in the balance of the Term Loan Warrants was due to the amendment of the Term Loan Warrants, which reduced the exercise price from $92.50 per share to $20.50 per share which resulted in an increase in the fair value of the Term Loan Warrants of $0.8 million as of the Second Amendment Effective Date (as defined below) and the change in the fair value of the Term Loan Warrants resulting from the change in price of the Company's Class A common stock, the remaining contractual term and the risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
Common Stock Warrants
The Company determined the fair value of the Common Stock Warrants (as defined below), which were issued on December 13, 2023, using a Black-Scholes option-pricing model and the quoted price of the Company's Class A common stock. Volatility was based on the implied volatility derived from the average of the actual market activity of the Company's peer group and the Company's historical volatility. The expected life was based on the remaining contractual term of the Common Stock Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Common Stock Warrants expected life. The significant unobservable input used in the fair value measurement of the Common Stock Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively.
The following table presents significant assumptions utilized in the valuation of the Common Stock Warrants on September 30, 2024 and December 31, 2023:
September 30, 2024 |
December 31, 2023 |
|||||||
Risk-free rate |
3.6 |
% |
3.8 |
% |
||||
Dividend yield rate |
- |
- |
||||||
Volatility |
81.1 |
% |
75.2 |
% |
||||
Contractual term (in years) |
4.70 |
5.44 |
||||||
Exercise price |
$ |
11.24 |
$ |
11.24 |
The following table presents changes in the fair value of the Common Stock Warrants for the three and nine months ended September 30, 2024 (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||
2024 |
2024 |
|||||||
Balance, beginning of year |
$ |
2,801 |
$ |
2,707 |
||||
Change in fair value |
(1,183 |
) |
(1,089 |
) |
||||
Balance, end of period |
$ |
1,618 |
$ |
1,618 |
For the three and nine months ended September 30, 2024, the change in the fair value of the Common Stock Warrants resulted from the change in price of the Company's Class A common stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
4. Inventory
Inventory, net consists of the following (in thousands):
September 30, 2024 |
December 31, 2023 |
|||||||
Raw materials and work in process |
$ |
10,817 |
$ |
10,354 |
||||
Finished goods |
7,191 |
14,622 |
||||||
Total inventory |
$ |
18,008 |
$ |
24,976 |
In the three months ended September 30, 2024, management determined that it would no longer sell connected fitness inventory after December 31, 2024. Based on this decision, the Company recorded $1.2 million in adjustments in the three and nine months ended September 30, 2024 to reduce connected fitness inventory to net realizable value. In addition, the Company recorded $0.2 million in adjustments in the three and nine months ended September 30, 2024 to reduce nutrition and other inventory impacted by the Pivot.
Including the adjustments for the connected fitness inventory ($1.2 million) and the adjustments for nutrition and other inventory ($0.2 million) due to the impact of the Pivot, total adjustments to the carrying value of excess inventory and inventory on hand to net realizable value were $1.7 million and $2.8 million during the three and nine months ended September 30, 2024, respectively, and $4.3 million and $9.4 million during the three and nine months ended September 30, 2023, respectively. These adjustments are included in the unaudited condensed consolidated statements of operations as a component of nutrition and other cost of revenue and connected fitness cost of revenue. The Company recorded $0.5 million and $0.3 million of these adjustments in nutrition and other cost of revenue for the three and nine months ended September 30, 2024, respectively, and $0.9 million and $2.3 million during the three and nine months ended September 30, 2023, respectively. The Company also recorded $1.2 million and $2.5 million of these adjustments in connected fitness cost of revenue for the three and nine months ended September 30, 2024 respectively, and $3.4 million and $7.1 million during the three and nine months ended September 30, 2023, respectively.
5. Other Current Assets
Other current assets consist of the following (in thousands):
September 30, 2024 |
December 31, 2023 |
|||||||
Deferred Partner costs |
$ |
29,561 |
$ |
36,169 |
||||
Deposits |
1,794 |
6,788 |
||||||
Accounts receivable, net |
1,689 |
1,270 |
||||||
Other |
1,756 |
1,696 |
||||||
Total other current assets |
$ |
34,800 |
$ |
45,923 |
6. Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
September 30, 2024 |
December 31, 2023 |
|||||||
Computer software and web development |
$ |
229,855 |
$ |
229,527 |
||||
Computer equipment |
16,973 |
23,738 |
||||||
Buildings |
- |
5,158 |
||||||
Leasehold improvements |
4,600 |
4,600 |
||||||
Furniture, fixtures and equipment |
1,166 |
1,166 |
||||||
Computer software and web development projects in-process |
118 |
2,157 |
||||||
Property and equipment, gross |
252,712 |
266,346 |
||||||
Less: Accumulated depreciation |
(227,807 |
) |
(221,291 |
) |
||||
Total property and equipment, net |
$ |
24,905 |
$ |
45,055 |
On September 30, 2024, the Company announced the Pivot, which resulted in certain computer software and web development and computer equipment with a net book value of approximately $12.7 million that will no longer be used by the Company after December 31, 2024. The impact of the Pivot related to these long-lived assets was considered by management to be a triggering event that caused the Company to perform a recoverability test for its long-lived assets as of September 30, 2024. See Note 1, Description of Business and Summary of Significant Accounting Policies, for additional information on the Company's recoverability test for its long-lived assets.
The Company decreased the average remaining useful lives for the long-lived assets that were impacted by the Pivot from 25 months prior to the Pivot to 3 months after the Pivot. This resulted in accelerated depreciation expense for these assets being recorded in the three and nine months ended September 30, 2024 of $2.9 million and is expected to result in accelerated depreciation expense of $8.1 million being recorded in the quarter ending December 31, 2024.
On February 29, 2024, the Company sold its Van Nuys production facility which had a net carrying value of $4.8 million for $6.2 million. The Company recognized a gain on the sale of the facility of $0.8 million, which is recorded as a reduction in general and administrative expenses for the nine months ended September 30, 2024. Simultaneous with the sale, the Company entered into a five year lease of the facility at an annual base rate of $0.3 million per year which increases by 3% annually. The Company recorded at the inception of the lease a right-of-use asset and lease liability of $1.3 million using a discount rate of 12.5% and classified this lease as an operating lease.
The Company recorded depreciation expense related to property and equipment in the following expense categories of its unaudited condensed consolidated statements of operations, including the accelerated depreciation of $2.9 million related to the Pivot in the three and nine months ended September 30, 2024 as noted above, as follows (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
2024 |
2023 |
||||||||||||||
Cost of revenue |
$ |
2,101 |
$ |
4,582 |
$ |
6,384 |
$ |
14,791 |
|||||||||
Enterprise technology and development |
5,866 |
3,902 |
12,372 |
12,768 |
|||||||||||||
General and administrative |
- |
1 |
- |
2 |
|||||||||||||
Total depreciation |
$ |
7,967 |
$ |
8,485 |
$ |
18,756 |
$ |
27,561 |
7. Accrued Expenses
Accrued expenses consist of the followings (in thousands):
September 30, 2024 |
December 31, 2023 |
|||||||
Employee compensation and benefits (1) |
$ |
14,004 |
$ |
4,334 |
||||
Partner costs |
8,867 |
13,971 |
||||||
Sales and other taxes |
3,459 |
3,963 |
||||||
Inventory, shipping and fulfillment |
2,857 |
6,869 |
||||||
Information technology |
2,161 |
3,176 |
||||||
Outside professional services |
1,988 |
2,927 |
||||||
Advertising |
847 |
872 |
||||||
Other accrued expenses |
3,745 |
6,035 |
||||||
Total accrued expenses |
$ |
37,928 |
$ |
42,147 |
(1) Accrued employee compensation and benefits include accruals for termination and retention benefits of $5.3 million and approximately zero at September 30, 2024 and December 31, 2023, respectively. See Note 12, Restructuring., for additional information on the restructuring expenses and accruals.
Advertising costs, which are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs, were $5.1 million and $22.4 million for the three and nine months ended September 30, 2024, respectively, and $8.9 million and $26.0 million for the three and nine months ended September 30, 2023, respectively.
On September 29, 2023, the Company entered into a financing agreement with IPFS Corporation of California ("IPFS") to finance certain of its annual insurance premiums. The Company financed $2.5 million, which will be paid over a ten month period with the first payment due on November 1, 2023. The financing has an interest rate of 8.83% and IPFS has a security interest in the underlying policies that have been financed. The zero and $1.8 million outstanding as of September 30, 2024 and December 31, 2023, respectively, is recorded in other current liabilities in the condensed consolidated balance sheet and the interest expense is recorded in interest expense in the condensed consolidated statement of operations.
On October 6, 2023, the Company entered into a financing agreement with First Insurance Funding ("FIF") to finance certain of its annual insurance premiums. The Company financed $2.0 million, which will be paid over a nine month period with the first payment due on November 1, 2023. The financing has an interest rate of 8.75% and FIF has a security interest in the underlying policies that have been financed. The zero and $1.4 million outstanding as of September 30, 2024 and December 31, 2023, respectively, is recorded in other current liabilities in the condensed consolidated balance sheet and the interest expense is recorded in interest expense in the condensed consolidated statement of operations.
8. Commitments and Contingencies
Inventory Purchase and Service Agreements
The Company has noncancelable inventory purchase and service agreements with multiple service providers which expire at varying dates through 2028. During the three and nine months ended September 30, 2024 and 2023, there were no losses on inventory purchase commitments. Service agreement obligations include amounts related to fitness and nutrition trainers, future events, information systems support, and other technology projects.
Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding September 30, 2024 are as follows (in thousands):
Three months ending December 31, 2024 |
$ |
9,979 |
||
Year ending December 31, 2025 |
4,968 |
|||
Year ending December 31, 2026 |
693 |
|||
Year ending December 31, 2027 |
100 |
|||
Year ending December 31, 2028 |
75 |
|||
$ |
15,815 |
The preceding table excludes royalty payments to fitness trainers, talent, and others that are based on future sales as such amounts cannot be reasonably estimated. During the nine months ended September 30, 2024 the Company paid $2.9 million of royalty payments exclusive of guaranteed payments.
Lease Commitments
The Company leases facilities under noncancelable operating leases expiring through 2029. These lease obligations will require payments of approximately $0.4 million during the three months ending December 31, 2024, $1.0 million for the year ending December 31, 2025 and $2.0 million in total thereafter through 2029.
Contingencies
The Company is subject to litigation from time to time in the ordinary course of business. Such claims typically involve its products, intellectual property, and relationships with suppliers, customers, distributors, employees, and others. Contingent liabilities are recorded when it is both probable that a loss has occurred and the amount of the loss can be reasonable estimated. Although it is not possible to predict how litigation and other claims will be resolved, the Company does not believe that any currently identified claims or litigation matters will have a material adverse effect on its consolidated financial position or results of operations.
On May 22, 2023, Jessica Lyons, an individual, and a group of other plaintiffs filed a class action complaint with the Los Angeles County Superior Court alleging that the Company misclassified its Partners as contractors rather than as employees and committed other violations of the California Labor Code. The Company understands that the plaintiffs in this matter intend on filing additional claims under the Private Attorney General Act of 2004. The Company and certain executive officers are listed as defendants in the complaint. The plaintiffs are seeking monetary damages. The Company filed a motion to compel arbitration in the case. The firm representing Ms. Lyons has also filed 13 arbitration actions in Los Angeles County in anticipation that the Company's motion to compel arbitration will be upheld. All arbitration proceedings have been stayed pending the outcome of the mediation and follow-up discussions. This matter is pending as of the date of this quarterly report. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
On September 6, 2023 Dish Technologies LLC and SLING TV LLC (the "DISH Entities") filed a complaint with the United States District Court for the District of Delaware alleging that the Company infringed on the DISH Entities' patents and used technology belonging to the DISH Entities without their permission. The plaintiffs are seeking monetary damages and injunctive relief. In an effort to avoid any further unnecessary litigation costs, the parties entered into a Confidential Standstill and Tolling Agreement as of April 16, 2024 which included a dismissal of the case by the DISH Entities without prejudice and an agreement by the DISH Entities not to institute any litigation proceedings against the Company under the patents any earlier than December 31, 2026 in exchange for a one-time immaterial payment to the DISH Entities by the Company.
On June 14, 2024, Bryan Reilly on behalf of himself and similarly situated current and former stockholders of Forest Road Acquisition Corp., which later became the Beachbody Company, Inc. ("Forest Road"), filed a verified class action complaint (the "Reilly Action") against the former directors and officers of Forest Road, as well as Forest Road Acquisition Sponsor LLC, Forest Road Company LLC, Zach Tarica, and Jeremy Tarica (together the "Forest Road Sponsor Defendants") alleging claims for breach of fiduciary duty in connection with the merger among Forest Road, The Beachbody Company, Inc., and Myx in 2021 (the "Merger"). The lawsuit also brought claims against the Company, Kevin Meyer, and The Raine Group LLC ("Raine") alleging aiding and abetting breach of fiduciary duty, and against the former Forest Road directors and officers, the Forest Road Sponsor Defendants, Raine, and Meyer for unjust enrichment. We also have certain indemnification obligations as to some or all of the former Forest Road directors and Raine as to certain claims.
The Reilly Action generally alleges that the proxy that Forest Road issued prior to the Merger contained numerous material misstatements and omissions that impaired the Forest Road stockholders' ability to make an informed decision regarding whether to redeem their stock in connection with the Merger. The plaintiff also asserts that the Merger was a conflicted transaction because the Forest Road Sponsor
Defendants and the former Forest Road directors were incentivized to close the Merger even if it was a value-decreasing transaction for Forest Road's public stockholders. As to the Company, Meyer, and Raine, the complaint alleges that these defendants aided and abetted the Forest Road defendants' disclosure violations. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
On October 14, 2024, the firm Milberg Coleman Bryson Phillips Grossman ("Milberg") filed 10 arbitration demands alleging that the Company violated the Video Privacy Protection Act. The arbitration demands state that Milberg currently represents approximately 6,239 additional subscribers of BODi and intends to file similar demands for each person. the plaintiffs are seeking monetary damages as well as injunctive and equitable relief. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
Some of our legal proceedings, such as the above referenced complaints, may be based on complex claims involving substantial uncertainties and unascertainable damages. Accordingly, it is not possible to determine the probability of loss or estimate damages for any of the above matters, and therefore the Company has not established reserves for any of these proceedings. When the Company determines that a loss is both probable and reasonably estimable, the Company records a liability, and, if the liability is material, discloses the amount of the liability reserved. Given that such proceedings are subject to uncertainty, there can be no assurance that such legal proceedings, either individually or in the aggregate, will not have a material adverse effect on our business, results of operations, financial condition or cash flows.
9. Debt
On August 8, 2022 (the "Effective Date"), the Company, Beachbody, LLC as borrower (a wholly owned subsidiary of the Company), and certain other subsidiaries of the Company as guarantors (the "Guarantors"), the lenders (the "Lenders"), and Blue Torch Finance, LLC, ("Blue Torch") as administrative agent and collateral agent for such lenders (the "Term Loan Agent") entered into a financing agreement which was subsequently amended (collectively with any amendments thereto, the "Financing Agreement"). The Financing Agreement provides for senior secured term loans on the Effective Date in an aggregate principal amount of $50.0 million (the "Term Loan") which was drawn on the Effective Date. In addition, the Financing Agreement permits the Company to borrow up to an additional $25.0 million, subject to the terms and conditions set forth in the Financing Agreement. Borrowings under the Term Loan are unconditionally guaranteed by the Guarantors, and all present and future material U.S. and Canadian subsidiaries of the Company. Such security interest consists of a first-priority perfected lien on substantially all property and assets of the Company and subsidiaries, including stock pledges on the capital stock of the Company's material and direct subsidiaries, subject to customary carveouts. In connection with the Financing Agreement, the Company incurred $4.2 million of third-party debt issuance costs which are recorded in the unaudited condensed consolidated balance sheets as a reduction of long-term debt as of September 30, 2024 and December 31, 2023 and are being amortized over the term of the Term Loan using the effective-interest method.
The Term Loan borrowings may take the form of base rate ("Reference Rate") loans or Secured Overnight Financing Rate ("SOFR Rate") loans. Reference Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 6.15% per annum, plus the greater of (a) 2.00% per annum, (b) the Federal Funds Rate plus 0.50% per annum, (c) the SOFR Rate (based upon an interest period of one month) plus 1.00% per annum, and (d) the rate last quoted by The Wall Street Journal. SOFR Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 7.15% and the SOFR Rate (based upon an interest period of three months). The SOFR Rate is subject to a floor of 1.00%. In addition, the Term Loan borrowings bear additional interest at 3.00% per annum, paid in kind by capitalizing such interest and adding such capitalized interest to the outstanding principal amount of the Term Loan on each anniversary of the Effective Date. The Term Loan was a SOFR Rate loan, with an effective interest rate of 23.35% and a cash interest rate of 12.77% for the nine months ended September 30, 2024. The Company recorded $1.6 million and $5.0 million of interest related to the Term Loan during the three and nine months ended September 30, 2024, respectively.
On July 24, 2023 (the "Second Amendment Effective Date"), the Company and Blue Torch entered into Amendment No. 2 to the Financing Agreement (the "Second Amendment"), which amended the Company's existing Financing Agreement. The Second Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to, (1) amended the minimum revenue financial covenant to test revenue levels for each fiscal quarter on a standalone basis, and to adjust the minimum revenue levels to (a) $100.0 million, commencing with the fiscal quarter ended June 30, 2023, for each fiscal quarter ending on or prior to March 31, 2024 and (b) $120.0 million for each fiscal quarter thereafter and or prior to December 31, 2025; (2) amended the minimum liquidity financial covenant to adjust the minimum liquidity levels to (a) $20.0 million at all times from the Second Amendment Effective Date through March 31, 2024 and (b) $25.0 million at all times thereafter through the maturity of the Term Loan; (3) modified the maturity date of the Term Loan from August 8, 2026 to February 8, 2026; and (4) amended certain financial definitions, reporting covenants and other covenants thereunder.
In connection with the Second Amendment, on the Second Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $15.0 million along with the related prepayment premium of 5% ($0.8 million) and accrued interest ($0.1 million). The Company also incurred a 1% fee as paid in kind on the outstanding Term Loan balance prior to the prepayment (fee of $0.5 million) which is recorded as incremental third party debt issuance costs and is being amortized over the amended term of the Term Loan using the effective-interest method. The partial prepayment of $15.0 million was accounted for as a partial debt extinguishment and the Company wrote off the proportionate amount of unamortized debt discount and debt issuance costs as of the Second Amendment Effective Date ($2.4 million) which in addition to the prepayment premium ($0.8 million) was recorded as a loss on partial debt extinguishment of $3.2 million in the three months ended September 30, 2023.
On January 9, 2024 (the "Third Amendment Effective Date"), the Company and Blue Torch entered into Consent No. 1 and Amendment No. 3 to the Financing Agreement (the "Third Amendment"), which amended the Company's existing Financing Agreement. The Third Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to, amended the minimum liquidity financial covenant to adjust the minimum liquidity levels to (a) $19.0 million at all times from the Third Amendment Effective Date through March 31, 2024 and (b) $24.0 million at all times thereafter through the maturity of the Term Loan.
In connection with the Third Amendment, on the Third Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $1.0 million along with the related prepayment premium of 3% and accrued interest. The partial prepayment of $1.0 million was accounted for as a partial debt extinguishment and the Company wrote off the proportionate amount of unamortized debt discount and debt issuance costs as of the Third Amendment Effective Date ($0.2 million) which in addition to the prepayment premium was recorded as a loss on partial debt extinguishment of $0.2 million in the three months ended March 31, 2024.
On February 29, 2024 (the "Fourth Amendment Effective Date"), the Company and Blue Torch entered into Consent No. 2 and Amendment No. 4 to the Financing Agreement (the "Fourth Amendment"), which amended the Company's existing Financing Agreement. The Fourth Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to amended the minimum liquidity financial covenant to adjust the minimum liquidity levels to (a) $17.0 million at all times from the Fourth Amendment Effective Date through March 31, 2024 and (b) $22.0 million at all times thereafter through the maturity of the Term Loan.
In connection with the Fourth Amendment, on the Fourth Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $5.5 million along with the related prepayment premium of 3% ($0.2 million) and accrued interest. The partial prepayment of $5.5 million was accounted for as a partial debt extinguishment and the Company wrote off the proportionate amount of unamortized debt discount and debt issuance costs as of the Fourth Amendment Effective Date ($0.8 million) which in addition to the prepayment premium ($0.2 million) was recorded as a loss on partial debt extinguishment of $1.0 million in the three months ended March 31, 2024.
On April 5, 2024 (the "Fifth Amendment Effective Date") the Company and Blue Torch entered into Amendment No. 5 to the Financing Agreement (the "Fifth Amendment") which amended the Company's existing Financing Agreement. The Fifth Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to 1) amending the minimum revenue financial covenant to adjust the minimum revenue levels to (a) $100.0 million, for each fiscal quarter ending on or prior to December 31, 2024 and (b) $110.0 million for each fiscal quarter thereafter and or prior to December 31, 2025 and (2) amending the minimum liquidity financial covenant to adjust the minimum liquidity level to $18.0 million at all times from the Fifth Amendment Effective Date through the maturity of the Term Loan. The Company was in compliance with these covenants as of September 30, 2024.
In connection with the Fifth Amendment, on the Fifth Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $4.0 million along with the related prepayment premium of 3% ($0.1 million) and accrued interest. The Company also incurred a 2% fee as paid in kind on the outstanding Term Loan balance prior to the prepayment (fee of $0.6 million) which is recorded as incremental third party debt issuance costs and is being amortized over the amended term of the Term Loan using the effective-interest method. The partial prepayment of $4.0 million was accounted for as a partial debt extinguishment and the Company wrote off the proportionate amount of unamortized debt discount and debt issuance costs as of the Fifth Amendment Effective Date ($0.6 million) which in addition to the prepayment premium ($0.1 million) was recorded as a loss on partial debt extinguishment of $0.7 million in the three months ended June 30, 2024. As of September 30, 2024, the principal balance outstanding (including capitalized paid in kind interest) under the Term Loan was $25.3 million.
On October 18, 2024, (the "Sixth Amendment Effective Date"), the Company and Blue Torch entered into Amendment No. 6 to the Financing Agreement (the "Sixth Amendment"), which among other things, (1) removed the minimum revenue financial covenant, (2) amended the minimum liquidity financial covenant, (3) included a minimum consolidated EBITDA (as defined in the Financing Agreement) financial covenant, (4) increased the quarterly principal payments on the Term Loan over the remaining quarterly periods, payable in monthly installments, until the maturity of the Term Loan, and (5) modified certain financial definitions, reporting covenants and other covenants thereunder. See Note 15, Subsequent Events, for additional information on the Sixth Amendment, including amendments to the financial covenants.
If there is an event of default, including not being in compliance with either of the financial covenants, the Term Loan will bear interest from the date of such event of default until the event of default is cured or waived in writing by the Lenders at the Post Default Rate, which is the rate of interest in effect pursuant to the Financing Agreement plus 2.00%. In the event of default, or voluntary prepayment of a portion of the Term Loan by the Company, the Lenders could also require repayment of the outstanding balance of the Term Loan including the prepayment premium of (a) 5.0% if repaid before the 1st anniversary of the Effective Date, (b) 3.0% if repaid before the 2nd anniversary of the Effective Date, (c) 2.0% if repaid before the 3rd anniversary date of the Effective Date, and (d) 0.0% if repaid after the 3rd anniversary date of the Effective Date.
The Financing Agreement also contains customary representations, warranties, and covenants, which include, but are not limited to, restrictions on indebtedness, liens, restricted payments, asset sales, affiliate transactions, changes in line of business, investments, negative pledges and amendments to organizational documents and material contracts. The Financing Agreement contains customary events of default, which among other things include (subject to certain exceptions and cure periods): (1) failure to pay principal, interest, or any fees or certain other amounts when due; (2) breach of any representation or warranty, covenant, or other agreement in the Financing Agreement and other related loan documents; (3) the occurrence of a bankruptcy or insolvency proceeding with respect to any Loan Party; (4) any failure by a Loan Party to make a payment with respect to indebtedness having an aggregate principal amount in excess of a specified threshold; and (5) certain other customary events of default.
In connection with the Term Loan, the Company issued to certain holders affiliated with Blue Torch warrants for the purchase of 94,335 shares of the Company's Class A common stock at an exercise price of $92.50 per share (the "Term Loan Warrants"). The Term Loan Warrants vest on a monthly basis over four years, with 30%, 30%, 20% and 20% vesting in the first, second, third and fourth years, respectively. The Term Loan Warrants have a seven-year term from the Effective Date. See Note 3, Fair Value Measurements, for information on the valuation of the Term Loan Warrants and Note 15, Subsequent Events, for information on amendments to the Term Loan Warrants. The Term Loan Warrants were recorded in the unaudited condensed consolidated balance sheets as warrant liabilities. The initial fair value of the Term Loan Warrants, of $5.2 million, is being amortized as a debt discount over the term of the Term Loan using the effective-interest method. In connection with the Second Amendment, the Company also amended and restated the Term Loan Warrants (the "Warrant First Amendment"). The amendment of the Term Loan Warrants amended the exercise price of the Term Loan Warrants from $92.50 per share to $20.50 per share. The amended exercise price increased the fair value of the Term Loan Warrants as of the Second Amendment Effective Date by $0.8 million and was recorded as of the Second Amendment Effective Date as an incremental debt discount, and in addition to the remaining debt discount is being amortized over the amended term of the Term Loan using the effective-interest method. In connection with the Equity Offering (as defined below), the Term Loan Warrants conversion ratio was amended resulting in an increase in the number of shares purchased upon the exercise of the Term Loan Warrants to 97,482 shares of the Company's Class A common stock. In connection with the Fifth Amendment, the Company also amended and restated the Term Loan Warrants (the "Warrant Second Amendment"). The Warrant Second Amendment amended the exercise price of the Term Loan Warrants from $20.50 per share to $9.16 per share. The amended exercise price increased the fair value of the Term Loan Warrants as of the Fifth Amendment Effective Date by $0.1 million and was recorded as of the Fifth Amendment Effective Date as an incremental debt discount, and in addition to the remaining debt discount is being amortized over the amended term of the Term Loan using the effective interest method.
In connection with the Sixth Amendment, the Company also amended and restated the Term Loan Warrants for the purchase of 97,482 shares of the Company's Class A common stock. The amendment of the Term Loan Warrants amends the exercise price from $9.16 per share to $6.26 per share.
The aggregate amounts of payments due for the periods succeeding September 30, 2024 and reconciliation of the Company's debt balances, net of debt discount and debt issuance costs, are as follows (in thousands):
Three months ending December 31, 2024 |
$ |
3,829 |
||
Year ending December 31, 2025 |
9,500 |
|||
Year ending December 31, 2026 |
11,834 |
|||
Total debt |
25,163 |
|||
Less current portion |
(11,704 |
) |
||
Less unamortized debt discount and debt issuance costs |
(3,553 |
) |
||
Add capitalized paid-in-kind interest |
113 |
|||
Total long-term debt |
$ |
10,019 |
The payments in the three months ended December 31, 2024 include partial prepayments of $3.2 million which were paid on October 18, 2024 as part of the Sixth Amendment, see Note 15, Subsequent Events, for more information on the amendment of the Term Loan.
Principal payments on the Term Loan are $1.3 million from the Effective Date to September 30, 2024, payable on a quarterly basis and thereafter, are $2.5 million per year, payable on a quarterly basis, with the remaining principal amount due on the maturity date of the Term Loan.
Quarterly principal payments on the Term Loan were amended with the Sixth Amendment, payable in monthly installments, and were increased by (a) $3.0 million for the three months ended March 31, 2025, (b) $2.0 million for the three months ended June 30, 2025, (c) $1.0 million for the three months ended September 30, 2025 and (d) $1.0 million for the three months ended December 31, 2025. Quarterly principal payments on the Term Loan, after reflecting the changes in quarterly principal payments due to the Sixth Amendment, are as follows (in thousands):
Three months ended December 31, 2024(1) $ 625
Three months ended March 31, 2024 ($1.0 million due monthly) 3,625
Three months ended June 30, 2025 ($0.7 million due monthly) 2,625
Three months ended September 30, 2025 ($0.3 million due monthly) 1,625
Three month ended December 31, 2025 ($0.3 million due monthly) 1,625
(1) Excludes $3.2 million of Term Loan prepayments that the Company made on October 18, 2024.
See Note 15, Subsequent Events, for more information on the amendments of the Term Loan.
At September 30, 2024 and December 31, 2023, the Company had one irrevocable standby letter of credit outstanding, totaling $0.1 million which is collateralized by $0.1 million of cash. This letter of credit expires on December 6, 2024 and is automatically extended for one-year terms unless notice of non-renewal is provided 60 days prior to the end of the applicable term. At September 30, 2024 and December 31, 2023, the cash collateralizing this letter of credit is classified as current restricted cash in our unaudited condensed consolidated balance sheet.
10. Stockholders' Equity
As of September 30, 2024, 2,000,000,000 shares, $0.0001 par value per share are authorized, of which, 1,600,000,000 shares are designated as Class A common stock, 200,000,000 shares are designated as Class X common stock, 100,000,000 shares are designated as Class C common stock and 100,000,000 shares are designated as preferred stock.
Holders of each share of each class of Common Stock are entitled to dividends when, as, and if declared by the Company's Board, subject to the rights and preferences of any holders of Preferred Stock outstanding at the time. As of September 30, 2024, the Company had not declared any dividends. The holder of each Class A common stock is entitled to one vote, the holder of each share of Class X common stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C common stock is not entitled to any voting powers.
On December 10, 2023, the Company entered into a securities purchase agreement for the issuance and sale of 420,769 shares of Class A common stock at a purchase price of $9.75 per share and pre-funded warrants to purchase up to 122,821 shares of Class A common stock at a pre-funded purchase price of $9.7499 per share with certain institutional investors in a registered direct offering. The pre-funded warrants were immediately exercisable and had an exercise price of $0.0001 per share. The pre-funded warrants are exercisable at any time after their original issuance at the option of the holder, in the holder's discretion, by (1) payment in full in cash for the number of shares of common stock purchased upon such exercise or (2) a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined accruing to the formula set forth in the pre-funded warrant. The Company also issued 543,590 warrants (the "Common Stock Warrants") to purchase 543,590 shares of Class A common stock at an exercise price of $11.24 per share in a concurrent private placement. The issuance of the Class A common stock, the pre-funded warrants and the Common Stock Warrants is collectively called the "Equity Offering". On January 12, 2024, all of the pre-funded warrants were exercised by the investor and converted into 122,821 shares of Class A common stock.
On June 15, 2023, the Company and Carl Daikeler, the Company's co-founder and CEO entered into a forfeiture agreement ("the Forfeiture Agreement"), pursuant to which Mr. Daikeler as of June 15, 2023 forfeited 160,000 shares of the Company's common stock that he owned, comprised of 63,999 shares of Class A common stock and 96,001 shares of Class X common stock, each with a par value of $0.0001. No consideration was provided to Mr. Daikeler for the forfeiture of these shares.
Reverse Stock Split
At the 2023 Annual Shareholder Meeting, which was held on November 20, 2023, our stockholders approved an amendment to our second amended and restated certificate of incorporation to effect a reverse stock split of all of our issued and outstanding common stock by a ratio in the range of 1-for-10 to 1-for-50. On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. The reverse stock split ratio and the implementation and the timing of the reverse stock split were determined by our Board. The reverse stock split did not change the authorized number of shares or the par value of our common stock or preferred
stock, but did effect a proportional adjustment to the number of common stock outstanding, the per share exercise price and the number of shares of common stock issuable upon the exercise of outstanding stock options, the number of shares of common stock issuable upon the vesting of restricted stock awards ("RSU's"), the number of shares of common stock under the Employee Stock Purchase Plan (the "ESPP"), the conversion rate of our outstanding warrants into common stock and the number of shares of common stock eligible for issuance under our 2021 Stock Plan (the "2021 Plan"). No fractional shares were issued in connection with the reverse stock split. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split.
All applicable outstanding equity awards discussed below in Note 11, Equity-Based Compensation, have been adjusted retroactively for the 1-for-50 reverse stock split.
Accumulated Other Comprehensive Income (Loss)
The following tables summarize changes in accumulated other comprehensive income (loss) by component during the three months ended September 30, 2024 and 2023 (in thousands):
Total1 |
||||
Balances at June 30, 2023 |
$ |
(333 |
) |
|
Other comprehensive loss before reclassifications |
(57 |
) |
||
Amounts reclassified from accumulated other comprehensive income |
157 |
|||
Tax effect |
38 |
|||
Balances at September 30, 2023 |
$ |
(195 |
) |
|
Balances at June 30, 2024 |
$ |
11 |
||
Other comprehensive loss before reclassifications |
22 |
|||
Amounts reclassified from accumulated other comprehensive income (loss) |
- |
|||
Tax effect |
- |
|||
Balances at September 30, 2024 |
$ |
33 |
1Total denotes unrealized gain (loss) on derivatives and foreign currency translation adjustments.
The following tables summarize changes in accumulated other comprehensive income (loss) by component during the nine months ended September 30, 2024 and 2023 (in thousands):
Total1 |
||||
Balances at December 31, 2022 |
$ |
37 |
||
Other comprehensive loss before reclassifications |
(319 |
) |
||
Amounts reclassified from accumulated other comprehensive loss |
131 |
|||
Tax effect |
(44 |
) |
||
Balances at September 30, 2023 |
$ |
(195 |
) |
|
Balances at December 31, 2023 |
$ |
(23 |
) |
|
Other comprehensive loss before reclassifications |
(24 |
) |
||
Amounts reclassified from accumulated other comprehensive income |
64 |
|||
Tax effect |
16 |
|||
Balances at September 30, 2024 |
$ |
33 |
1Total denotes unrealized gain (loss) on derivatives and foreign currency translation adjustments.
11. Equity-Based Compensation
Equity Compensation Plans
A summary of the option activity under the Company's equity compensation plans is as follows:
Time Vested Options Outstanding |
|||||||||||||||
Number of Options |
Weighted-Average Exercise Price |
Weighted-Average Remaining Contractual Term |
Aggregate Intrinsic Value |
||||||||||||
Outstanding at December 31, 2023 |
839,479 |
$ |
32.53 |
7.25 |
$ |
- |
|||||||||
Forfeited |
(58,062 |
) |
18.58 |
||||||||||||
Expired |
(40,053 |
) |
17.35 |
||||||||||||
Outstanding at September 30, 2024 |
741,364 |
$ |
34.44 |
6.64 |
$ |
- |
|||||||||
Exercisable at September 30, 2024 |
436,259 |
$ |
38.30 |
5.65 |
$ |
- |
Performance Vested Options Outstanding |
|||||||||||||||
Number of Options |
Weighted-Average Exercise Price |
Weighted-Average Remaining Contractual Term |
Aggregate Intrinsic Value |
||||||||||||
Outstanding at December 31, 2023 |
318,440 |
$ |
22.02 |
9.45 |
$ |
- |
|||||||||
Outstanding at September 30, 2024 |
318,440 |
$ |
22.02 |
8.70 |
$ |
- |
|||||||||
Exercisable at September 30, 2024 |
- |
$ |
- |
- |
$ |
- |
A summary of restricted stock unit ("RSU") activity is as follows:
RSUs Outstanding |
||||||||||
Number of RSUs |
Weighted-Average Fair Value |
|||||||||
Outstanding at December 31, 2023 |
301,881 |
$ |
31.97 |
|||||||
Granted |
260,321 |
7.77 |
||||||||
Vested |
(87,172 |
) |
29.12 |
|||||||
Forfeited |
(89,196 |
) |
19.24 |
|||||||
Outstanding at September 30, 2024 |
385,834 |
$ |
15.64 |
The fair value of RSUs vested during the three and nine months ended September 30, 2024 was approximately zero and $2.5 million, respectively. $0.1 million and $7.7 million was the fair value of RSUs vested during the three and nine months ended September 30, 2023, respectively.
On January 1, 2024, the number of shares available for issuance under the 2021 Incentive Award Plan (the "2021 Plan") increased by 335,295 pursuant to the terms of the 2021 Plan. On June 4, 2024, the number of shares available for issuance under the 2021 Plan increased by 350,000 pursuant to an amendment to the 2021 Plan, which was approved by the Company's stockholders at the Company's annual stockholder meeting. As of September 30, 2024, 850,694 shares of Class A common stock were available for issuance under the 2021 Plan.
Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company withheld shares of common stock with an aggregate fair value and remitted taxes of $0.2 million during the nine months ended September 30, 2024, which were classified as financing cash outflows in the unaudited condensed consolidated statements of cash flows. The Company canceled and returned these shares to the 2021 Plan, which are available under the plan terms for future issuance.
On June 14, 2023, the Board adopted the Company's 2023 Employment Inducement Incentive Award Plan (the "Inducement Plan") for the grant of non-qualified stock options, stock appreciation rights, restricted stock, RSU's, dividend equivalents and other stock or cash-based awards to prospective employees. The Board reserved 477,661 shares of the Company's common stock for issuance pursuant to the awards granted under the Inducement Plan.
Effective as of June 15, 2023, the Company appointed Mark Goldston as Executive Chairman, replacing the service of Mr. Daikeler in his capacity as Chairman of the Board. Mr. Daikeler continues to serve as the Company's CEO and as a director. In connection with the employment offer letter to Mr. Goldston, he was granted a stock option under the Inducement Plan, covering an aggregate of 477,661 shares of the Company's Class A common stock, par value $0.0001 per share (the "Option"). Of this amount, 159,221 shares subject to the Option will vest based on continued service (the "Time-Vesting Options") and 318,440 shares will vest based on the attainment of applicable performance goals and continued service (the "Performance-Vesting Options"). The Time-Vesting Options will vest and become exercisable with respect to 25% of the Time-Vesting Options subject to the Option on each of the first four anniversaries of June 15, 2023. The Performance-Vesting Options will vest and become exercisable based on both (1) the achievement of pre-determined price per share goals and (2) Mr. Goldston's service through the applicable vesting date. Any earned Performance-Vesting Options will vest and become exercisable as of the later of (1) June 15, 2024, and (2) the date on which the applicable price per share goal is achieved. The weighted average exercise price of the Performance-Vesting Options was $22.02 per option and none of the Performance-Vesting Options were exercisable as of September 30, 2024.
Vesting tranche Number of Performance -Vesting Options Price per share goal
Tranche 1 79,610 $50.00
Tranche 2 79,610 $75.00
Tranche 3 79,610 $100.00
Tranche 4 79,610 $125.00
The share price is measured by averaging the fair market value (as defined in the Inducement Plan) per share over any 30 consecutive trading-day period.
Employee Stock Purchase Plan
In May 2022, the Company established an ESPP, the terms of which allow for qualified employees to participate in the purchase of designated shares of the Company's common stock at a price equal to 85% of the lower of the closing price at the beginning or ending of each six-month purchase period.
On January 1, 2024, the number of shares available for issuance under the ESPP increased by 67,059 pursuant to the terms of the ESPP. As of September 30, 2024, 180,742 shares of Class A common stock were available for issuance under the ESPP.
During the nine months ended September 30, 2024, 24,293 shares of the Company's common stock were issued pursuant to the ESPP at an average price of $6.80 per share.
Equity-Based Compensation Expense
Equity-based compensation expense for the three and nine months ended September 30, 2024 and 2023 was as follows (in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Cost of revenue |
$ |
274 |
$ |
795 |
$ |
1,005 |
$ |
2,551 |
||||||||
Selling and marketing |
1,562 |
2,689 |
4,955 |
7,846 |
||||||||||||
Enterprise technology and development |
233 |
394 |
717 |
1,097 |
||||||||||||
General and administrative |
1,522 |
2,558 |
6,018 |
7,658 |
||||||||||||
Total equity-based compensation |
$ |
3,591 |
$ |
6,436 |
$ |
12,695 |
$ |
19,152 |
In connection with the restructuring activities that took place during the three and nine months ended September 30, 2024 and 2023, the Company modified certain stock awards of terminated employees (approximately 150 employees in the three month period ended September 30, 2024, approximately 40 employees in the three month period ended March 31, 2024, approximately 25 employees in the three month period ended September 30, 2023 and approximately 100 employees in the three month period ended March 31, 2023). On September 30, 2024 the Company announced the Pivot which will result in the reduction of approximately 170 employees (33% of the Company's workforce on that date) in the fourth quarter of 2024 and the modification of certain stock awards for certain terminated employees. See Note 12, Restructuring, for additional information on the restructuring activities. The modifications for the Pivot included accelerating the vesting of any options that would have vested within six months of the employee's termination date, and all vested options will be available for exercise for a total of six months after the employee's termination date (that is, three months in
addition to the standard three months per original agreement). The modification for the other restructuring activities in the three and nine months ended September 30, 2024 and 2023 included accelerating the vesting of any options that would have vested within three months of the employees termination date, and all vested options will be available for exercise for a total of six months after the employees' termination date (that is, three months in addition to the standard three months per original agreement). As a result of these modifications, the Company recognized $0.3 million and $0.8 million reduction to equity-based compensation expense in the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2024, respectively, and approximately zero and $1.0 million for the three and nine months ended September 30, 2023, respectively.
Repricing of Stock Options
The Company determined that a significant portion of its outstanding stock options had an exercise price per share that was significantly higher than the current fair market value of the Company's common stock (the "Underwater Options"). In order to help retain and motivate holders of Underwater Options, and align their interests with those of stockholders, on September 14, 2023, the Compensation Committee of the Board resolved that it was in the best interests of the Company and its stockholders to amend certain of the Underwater Options (the "Amended Underwater Options") for current employees and consultants of the Company that were either (1) not maturing in fiscal 2023 or (2) that had not been issued at an exercise price of less than $50 in the prior twelve months, to reduce the exercise price of each Amended Underwater Option to the closing per share price of the Company's common stock on September 14, 2023 (the "Repricing"). The Company had 531,515 Amended Underwater Options which had their exercise price amended to $17.35 per option.
Excluded from the Repricing were, among others, Underwater Options held by members of the Board, the Company's CEO and Executive Chairman; any Underwater Options with an exercise price less than $50.00; and options granted to consultants who are no longer providing services to the Company. Except for the modification of the exercise price, all other terms and conditions of the Amended Underwater Options remain in effect.
The Company determined that the Repricing represented a modification of share-based awards under ASC 718. Accordingly, the Company recognized incremental stock-based compensation of $1.6 million which was recorded as of the Repricing, related to 255,174 vested Amended Underwater Options as of the Repricing. As of the Repricing $1.5 million incremental unrecognized compensation expense related to 276,341 unvested Amended Underwater Options will be recognized as expense over the requisite service period in which the options vest, or 1.6 years.
12. Restructuring
On September 30, 2024, the Company announced the Pivot which will convert the Company's MLM model to a single level affiliate model and will reduce the Company's headcount by approximately 170 employees (33% of the Company's workforce on that date) in the fourth quarter of 2024. The actions associated with the Pivot are expected to result in approximately $18.4 million in costs, with approximately $9.2 million recorded in the Company's unaudited condensed consolidated statement of operations in the three and nine months ending September 30, 2024, with approximately $9.2 million expected to be recorded in the three months ended December 31, 2024.
The following table details the costs incurred and benefits realized associated with the Pivot in the three and nine months ended September 30, 2024:
Pivot Restructuring |
Three and Nine months ended September 30, |
|||
(in thousands) |
2024 |
|||
Termination and retention benefits (1) |
$ |
5,087 |
||
Accelerated depreciation on long-lived assets (2) |
2,936 |
|||
Incremental inventory adjustments (3) |
1,444 |
|||
Modification of stock awards (4) |
(308 |
) |
||
Total Restructuring Costs |
$ |
9,159 |
||
(1) Termination and retention benefits which are included in restructuring expense in the Company's unaudited condensed consolidated statement of operations of approximately $5.1 million were recorded in the three and nine months ended September 30, 2024. The Company expects to record an additional $1.1 million in restructuring expense in the three months ended December 31, 2024.
(2) Due to the Pivot, certain long-lived assets with a net book value of approximately $12.7 million will not be used by the Company after December 31, 2024. The Company performed an impairment review for its long-lived assets, including the long-lived assets, which are all in one asset group, that will not be used after December 31, 2024. The Company performed a test of recoverability and concluded that the carrying value of its long-lived assets were recoverable. The Company decreased the average remaining useful lives for the long-lived assets that were impacted by the Pivot from 25 months prior to the Pivot to 3 months after the Pivot. This resulted in accelerated depreciation expense of $2.9 million that was recorded in the Company's unaudited condensed consolidated statement of operations in the three and nine months ended September 30, 2024 and $8.1 million which is expected to be recorded in the three months ended December 31, 2024. See Note 6, Property and Equipment, Net, for additional information on the accelerated depreciation.
(3) Consists of (a) inventory adjustments recorded associated with the decision by management to no longer sell connected fitness inventory after December 31, 2024, which was recorded in cost of revenue-connected fitness ($1.2 million) and (b) inventory adjustments for nutrition and other inventory impacted by the Pivot which was recorded in cost of revenue-nutrition and other ($0.2 million) in the unaudited condensed consolidated statement of operations in the three and nine months ended September 30, 2024. See Note 4, Inventory, for additional information on the incremental inventory adjustments.
(4) Modification of stock awards based compensation for employees who were impacted by the Pivot which includes accelerating the vesting of any options or RSU's that would have vested within six months of the employees termination date, and all vested options will be available for exercise for a total of six months after the employees termination date (that is, three month in addition to the standard three months per original agreement), which resulted in a decrease to equity based compensation expense of $0.3 million in the Company's unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2024. See Note 11, Equity Based Compensation, for more information on the modification of stock awards.
The Company expects to incur the remaining costs related to the Pivot primarily in the fourth quarter of 2024 and the charges are expected to be substantially completed by December 31, 2024. The estimates of the charges and expenditures that the Company expects to incur in connection with the Pivot, and the timing thereof, are subject to a number of assumptions and actual amounts may differ materially from the estimates. In addition, the Company may incur other cash or non-cash charges, or cash expenditures not currently contemplated due to unanticipated events that may occur as a result of, or in association with the Pivot.
In addition to the Pivot, the 2024 restructuring charges primarily relate to the Company's key initiatives. The Company recognized restructuring costs of $5.1 million and $6.7 million during the three and nine months ended September 30, 2024, respectively, comprised primarily of termination benefits related to headcount reductions.
Restructuring charges in 2023 primarily relate to activities focused on aligning the Company's operations with its key growth priorities. The Company recognized restructuring costs of $1.3 million and $6.6 million during the three and nine months ended September 30, 2023, respectively, comprised primarily of termination benefits related to headcount reductions.
In accordance with GAAP, employee termination benefits were recognized at the date employees were notified and post-employment benefits were accrued as the obligation was probable and estimable. Benefits for employees who provided service greater than 60 days from the date of notification were recognized ratably over the service period.
The following table summarizes activity in the Company's restructuring-related liability during the three months ended September 30, 2024 and 2023, respectively (in thousands):
Balance at |
Restructuring |
Payments / |
Liability at |
|||||||||||||
June 30, 2024 |
Charges |
Utilizations |
September 30, 2024 |
|||||||||||||
Employee-related costs |
$ |
17 |
$ |
5,087 |
$ |
149 |
$ |
5,253 |
||||||||
Total costs |
$ |
17 |
$ |
5,087 |
$ |
149 |
$ |
5,253 |
Balance at |
Restructuring |
Payments / |
Liability at |
|||||||||||||
June 30, 2023 |
Charges |
Utilizations |
September 30, 2023 |
|||||||||||||
Employee-related costs |
$ |
256 |
$ |
1,270 |
$ |
(215 |
) |
$ |
1,311 |
|||||||
Total costs |
$ |
256 |
$ |
1,270 |
$ |
(215 |
) |
$ |
1,311 |
The following table summarizes the activity in the Company's restructuring related liability during the nine months ended September 30, 2024 and 2023, respectively (in thousands):
Balance at |
Restructuring |
Payments / |
Liability at |
|||||||||||||
December 31, 2023 |
Charges |
Utilizations |
September 30, 2024 |
|||||||||||||
Employee-related costs |
$ |
18 |
$ |
6,731 |
$ |
(1,496 |
) |
$ |
5,253 |
|||||||
Total costs |
$ |
18 |
$ |
6,731 |
$ |
(1,496 |
) |
$ |
5,253 |
Balance at |
Restructuring |
Payments / |
Liability at |
|||||||||||||
December 31, 2022 |
Charges |
Utilizations |
September 30, 2023 |
|||||||||||||
Employee-related costs |
$ |
469 |
$ |
6,550 |
$ |
(5,708 |
) |
$ |
1,311 |
|||||||
Total costs |
$ |
469 |
$ |
6,550 |
$ |
(5,708 |
) |
$ |
1,311 |
The Company evaluated the requirements of ASC No. 205-20, Presentation of Financial Statements-Discontinued Operations, relative to the Pivot and determined that discontinued operations treatment is not applicable. Accordingly, the results of operations impacted by the Pivot are reported as part of continuing operations in the accompanying unaudited condensed consolidated financial statements.
13. Income Taxes
The Company recorded a provision for income taxes of $0.1 million and $0.2 million for the three and nine months ended September 30, 2024, respectively, and a provision for income taxes of $0.1 million for the three and nine months ended September 30, 2023, respectively. The effective tax rate was (1.0)% and (0.7)% for the three and nine months ended September 30, 2024, respectively, and the effective tax rate was (0.2)% and (0.1)% for the three and nine months ended September 30, 2023, respectively.
The tax provision for interim periods is determined using an estimate of the Company's annual effective tax rate, adjusted for discrete items arising in that quarter. The Company's effective tax rate differs from the U.S. statutory tax rate in the three and nine months ended September 30, 2024 primarily due to changes in valuation allowances on deferred tax assets as it is more likely than not that some or all of the Company's deferred tax assets will not be realized.
The Company evaluates its tax positions on a quarterly basis and revises its estimate accordingly. There were no material changes to the Company's uncertain tax positions, interest, or penalties during the three and nine months ended September 30, 2024.
14. Earnings (Loss) per Share
The computation of loss per share of Class A and Class X common stock is as follows (in thousands, except share and per share information):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Numerator: |
||||||||||||||||
Net loss |
$ |
(12,003 |
) |
$ |
(32,666 |
) |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
||||
Denominator: |
||||||||||||||||
Weighted-average common shares outstanding, basic and diluted |
6,840,960 |
6,178,622 |
6,804,959 |
6,215,874 |
||||||||||||
Net loss per common share, basic and diluted |
$ |
(1.75 |
) |
$ |
(5.29 |
) |
$ |
(5.45 |
) |
$ |
(14.09 |
) |
Basic net loss per common share is the same as dilutive net loss per common share for each of the three and nine months ended September 30, 2024 and 2023 as the inclusion of all potential common shares would have been antidilutive. The weighted average common shares outstanding (basic and diluted) in the above table exclude the 160,000 shares that were forfeited by Mr. Daikeler for the period of time after they were forfeited (June 15, 2023).
The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive:
September 30, |
||||||||
2024 |
2023 |
|||||||
Time vested options |
741,364 |
929,206 |
||||||
Performance vested options |
318,440 |
318,440 |
||||||
RSUs |
385,834 |
281,062 |
||||||
Compensation warrants |
79,612 |
79,612 |
||||||
Public and Private Placement Warrants |
306,667 |
306,667 |
||||||
Term Loan Warrants |
97,482 |
94,335 |
||||||
Common Stock Warrants |
543,590 |
- |
||||||
Forest Road Earn-out Shares |
75,000 |
75,000 |
||||||
2,547,989 |
2,084,322 |
See Note 11, Equity-Based Compensation, for additional information on the Performance-Vesting Options.
15. Subsequent Events
As mentioned in Note 9, Debt, on October 18, 2024 (the "Sixth Amendment Effective Date"), the Company and Blue Torch entered into the Sixth Amendment, which amended the Company's existing Financing Agreement. The Sixth Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to, (1) removed the minimum revenue financial covenant; (2) amended the minimum liquidity financial covenant to adjust the minimum liquidity levels to (a) $9.5 million at all times from the Sixth Amendment Effective Date to December 31, 2024 and (b) $13.0 million at all times thereafter through the maturity of the Term Loan; (3) included a minimum consolidated EBITDA (which is defined in the Financing Agreement as an adjusted EBITDA calculation) financial covenant of (a) $2.0 million for the three months ended December 31, 2024, (b) $4.5 million for the six months ended March 31, 2025, (c) $6.6 million for the nine months ended June 30, 2025, (d) $11.3 million for the 12 months ended September 30, 2025 and (e) $14.6 million for the 12 months ended December 31, 2025; (4) increased the quarterly principal payments on the Term Loan, payable in monthly installments, by (a) $3.0 million for the three months ended March 31, 2025, (b) $2.0 million for the three months ended June 30, 2025, (c) $1.0 million for the three months ended September 30, 2025 and (d) $1.0 million for the three months ended December 31, 2025, and (5) amended certain financial definitions, reporting covenants and other covenants thereunder.
In connection with the Sixth Amendment, on the Sixth Amendment Effective Date, the Company made partial prepayments on the Term Loan of $3.2 million (which amount was classified as a current obligation at September 30, 2024) along with a related prepayment premium of 2% on $2.0 million of the partial prepayments and accrued interest. The Company also incurred a 1% fee as paid in kind on the outstanding Term Loan balance prior to the prepayment (fee of $0.3 million). The amounts related to the Sixth Amendment will be recorded in the quarter ending December 31, 2024. After the prepayments and the paid in kind fee on October 18, 2024, the principal amount outstanding on the Term Loan was $22.3 million.
In connection with the Sixth Amendment, the Company also amended and restated the Term Loan Warrants for the purchase of 97,482 shares of the Company's Class A common stock. The amendment of the Term Loan Warrants amends the exercise price from $9.16 per share to $6.26 per share.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis should be read in conjunction with our financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (this "Report") as well as our financial statements and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report on Form 10-K for the year ended December 31, 2023 (our "Form 10-K"). Unless otherwise indicated, the terms "BODi," "we," "us," or "our" refer to The Beachbody Company, Inc., a Delaware corporation, together with its consolidated subsidiaries.
Forward-Looking Statements
This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements about the financial condition, results of operations, earnings outlook and prospects of the Company. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on our current expectations as applicable and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to the following:
Should one or more of these risks or uncertainties materialize or should any of the assumptions made by management prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.
You should not place undue reliance upon our forward-looking statements.
Except to the extent required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date of this Report or to reflect the occurrence of unanticipated events.
Overview
BODi is a leading fitness and nutrition company. We focus primarily on digital content, supplements, connected fitness, and consumer health and fitness. Our goal is to continue to provide holistic health and fitness content, subscription-based solutions and digital program sales. We are the creator of some of the world's most popular fitness programs, including P90X, Insanity, and 21 Day Fix, which transformed the at-home fitness market and disrupted the global fitness industry by making it accessible for people to get results-anytime, anywhere. Our comprehensive nutrition-first programs, Portion Fix and 2B Mindset, teach healthy eating habits and promote healthy, sustainable weight loss. These fitness and nutrition programs are available through our BODi streaming service.
We offer nutritional products such as Shakeology nutrition shakes, Beachbody Performance supplements and BEACHBAR snack bars, as well as a commercial-grade stationary cycle with or without a 360-degree touch screen tablet and connected fitness software. Leveraging our history of fitness content creation, nutrition innovation, and our network of micro-influencers, whom we call "Partners", we plan to continue market penetration into connected fitness to reach a wider health, wellness and fitness audience.
Our revenue is generated primarily through our network of Partners, social media marketing channels, and direct response advertising. Components of revenue include recurring digital subscription revenue, digital program sales, revenue from the sale of nutritional and other products, and connected fitness revenue. In addition to selling individual products on a one-time basis, we bundle digital and nutritional products together at discounted prices.
On September 30, 2024, the Company announced a restructuring of its network business (the "Pivot") which will convert the Company's multi-level marketing model ("MLM") to a single level affiliate model and will reduce the Company's headcount by approximately 170 employees (33% of the Company's workforce on that date) in the fourth quarter of 2024.
For the three months ended September 30, 2024, as compared to the three months ended September 30, 2023:
For the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023:
See "Non-GAAP Information" below for information regarding our use of Adjusted EBITDA and a reconciliation of net loss to Adjusted EBITDA.
Recent Developments
Pivot Restructuring
On September 30, 2024, the Company announced the Pivot which will convert the Company's MLM model to a single level affiliate model and will reduce the Company's headcount by approximately 170 employees (33% of the Company's workforce on that date) in the fourth quarter of 2024. The actions associated with the Pivot are expected to result in approximately $18.4 million in costs, with approximately $9.2 million recorded in the Company's unaudited condensed consolidated statement of operations in the three and nine months ending September 30, 2024 with approximately $9.2 million expected to be recorded in the three months ended December 31, 2024.
The following table details the costs incurred and benefits realized associated with the Pivot in the three and nine months ended September 30, 2024:
Pivot Restructuring |
Three and Nine months ended September 30, |
|||
(in thousands) |
2024 |
|||
Termination and retention benefits (1) |
$ |
5,087 |
||
Accelerated depreciation on long-lived assets (2) |
2,936 |
|||
Incremental inventory adjustments (3) |
1,444 |
|||
Modification of stock awards (4) |
(308 |
) |
||
Total Restructuring Costs |
$ |
9,159 |
||
(1) Termination and retention benefits which are included in restructuring expense in the Company's unaudited condensed consolidated statement of operations of approximately $5.1 million were recorded in the three and nine months ended September 30, 2024. The Company expects to record an additional $1.1 million in restructuring expense in the three months ended December 31, 2024.
(2) Due to the Pivot, certain long-lived assets with a net book value of approximately $12.7 million will not be used by the Company after December 31, 2024. The Company performed an impairment review for its long-lived assets, including the long-lived assets that will not be used after December 31, 2024. The Company performed a test of recoverability and concluded that the carrying value of its long-lived assets, which are all in one asset group, were recoverable. The Company decreased the average remaining useful lives for the long-lived assets that were impacted by the Pivot from 25 months prior to the Pivot to 3 months after the Pivot. This resulted in accelerated depreciation expense of $2.9 million that was recorded in the Company's unaudited condensed consolidated statement of operations in the three and nine months ended September 30, 2024 and $8.1 million which is expected to be recorded in the three months ended December 31, 2024. See Note 6, Property and Equipment, Net, for additional information on the accelerated depreciation.
(3) Consists of (a) inventory adjustments recorded associated with the decision by management to no longer sell connected fitness inventory after December 31, 2024, which was recorded in cost of revenue-connected fitness ($1.2 million) and (b) inventory adjustments for nutrition and other inventory impacted by the Pivot which was recorded in cost of revenue-nutrition and other ($0.2 million) in the unaudited condensed consolidated statement of operations in the three and nine months ended September 30, 2024. See Note 4, Inventory, for additional information on the incremental inventory adjustments.
(4) Modification of stock awards for employees who were impacted by the Pivot which includes accelerating the vesting of any options or restricted stock units ("RSU's") that would have vested within six months of the employees termination date, and all vested options will be available for exercise for a total of six months after the employees termination date (that is, three month in addition to the standard three months per original agreement), which resulted in a decrease to equity based compensation expense of $0.3 million in the Company's unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2024. See Note 11, Equity Based Compensation, for more information on the modification of stock awards.
Term Loan Amendment
On October 18, 2024, (the "Sixth Amendment Effective Date"), the Company and Blue Torch entered into Amendment No. 6 to the Financing Agreement (the "Sixth Amendment"), which amended the Company's existing Financing Agreement. The Sixth Amendment amends, among other things, certain terms of the Financing Agreement including without limitation, to (1) remove the minimum revenue financial covenant, (2) amend the minimum liquidity financial covenants, (3) include a minimum consolidated EBITDA (as defined in the Financing Agreement) financial covenant, (4) increase the quarterly principal payments on the Term Loan over the remaining quarterly periods, payable in monthly installments, until the maturity of the Term Loan, and (5) amend certain financial definitions, reporting covenants and other covenants thereunder.
In connection with the Sixth Amendment, on the Sixth Amendment Effective Date, the Company made partial prepayments on the Term Loan of $3.2 million (which amount was classified as a current obligation at September 30, 2024) along with the related
prepayment premium of 2% on $2.0 million of the partial prepayments and accrued interest. The Company also incurred a 1% fee as paid in kind on the outstanding Term Loan balance prior to the prepayment (fee of $0.3 million).
In connection with the Sixth Amendment, the Company also amended and restated the Term Loan Warrants for the purchase of 97,482 shares of the Company's Class A common stock. The amendment of the Term Loan Warrants amends the exercise price from $9.16 per share to $6.26 per share.
See Note 15, Subsequent Events, for additional information on the Sixth Amendment and amendments to the Term Loan Warrants.
Key Operational and Business Metrics
We use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts, and make strategic decisions.
As of September 30, |
||||||||
2024 |
2023 |
|||||||
Digital subscriptions (millions) |
1.11 |
1.38 |
||||||
Nutritional subscriptions (millions) |
0.13 |
0.18 |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Average digital retention |
97.3 |
% |
96.2 |
% |
96.5 |
% |
95.7 |
% |
||||||||
Total streams (millions) |
20.9 |
22.9 |
69.2 |
77.9 |
||||||||||||
DAU/MAU |
31.0 |
% |
30.8 |
% |
32.1 |
% |
31.6 |
% |
||||||||
Revenue (millions) |
$ |
102.2 |
$ |
128.3 |
$ |
332.4 |
$ |
408.1 |
||||||||
Gross profit (millions) |
$ |
68.8 |
$ |
75.0 |
$ |
226.5 |
$ |
249.1 |
||||||||
Gross margin |
67.3 |
% |
58.5 |
% |
68.1 |
% |
61.0 |
% |
||||||||
Net loss (millions) |
$ |
(12.0 |
) |
$ |
(32.7 |
) |
$ |
(37.1 |
) |
$ |
(87.6 |
) |
||||
Adjusted EBITDA (millions) (1) |
$ |
10.1 |
$ |
(5.8 |
) |
$ |
19.6 |
$ |
(11.5 |
) |
(1) Please see "Non-GAAP Information" below for a reconciliation of net loss to Adjusted EBITDA and an explanation for why we consider Adjusted EBITDA to be a helpful metric for investors.
Digital Subscriptions
Our ability to expand the number of digital subscriptions is an indicator of our market penetration and growth. Digital subscriptions include BOD (through March 2023) and BODi. Digital subscriptions include paid and free-to-pay subscriptions, with free-to-pay subscriptions representing less than 1% of total digital subscriptions on average. Digital subscriptions are inclusive of all billing plans, currently for annual, semi-annual, quarterly and monthly billing intervals.
Nutritional Subscriptions
Nutritional subscriptions include monthly subscriptions for nutritional products such as Shakeology, Beachbody Performance and BEACHBAR. We also package and bundle the content experience of digital subscriptions with nutritional subscriptions to optimize customer results.
Average Digital Retention
We use month-over-month digital subscription retention, which is defined as the average rate at which the total subscriber file is retained for the next period, to measure customer retention. For instance, a 95% average digital retention rate would correspond with retaining each month an average of 95% of digital subscribers existing at the beginning of that month. A 95% average digital retention rate would translate into a loss at the end of the quarter of approximately 15% of the subscribers existing at the beginning of the quarter. This calculation excludes new customer acquisitions or subscribers added in a specific month, so this calculation can never exceed 100%.
Total Streams
We use total streams to quantify the number of fitness, nutrition and mindset programs viewed, which is an indicator of customer engagement and retention. While the measure of a digital stream may vary across companies, to qualify as a stream on any of our digital platforms, a program must be viewed for a minimum of 25% of the total running time.
Daily Active Users to Monthly Active Users (DAU/MAU)
We use the ratio of daily active users to monthly active users to measure how frequently digital subscribers are utilizing our service in a given month. We define a daily active user as a unique user streaming content on our platform in a given day. We define a monthly active user as a unique user streaming content on our platform in that same month.
Non-GAAP Information
We use Adjusted EBITDA, which is a non-GAAP performance measure, to supplement our results presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We believe Adjusted EBITDA is useful in evaluating our operating performance, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. Adjusted EBITDA is not intended to be a substitute for any GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry.
We define and calculate Adjusted EBITDA as net income (loss) adjusted for depreciation and amortization, amortization of capitalized cloud computing implementation costs, amortization of content assets, interest expense, income tax provision, equity-based compensation, restructuring costs, and other items that are not normal, recurring, operating expenses necessary to operate the Company's business as described in the reconciliation below.
We include this non-GAAP financial measure because it is used by management to evaluate BODi's core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments. Adjusted EBITDA excludes certain expenses that are required in accordance with GAAP because they are non-cash (for example, in the case of depreciation and amortization and equity-based compensation) or are not related to our underlying business performance (for example, in the case of restructuring costs, interest income and expense).
The table below presents our Adjusted EBITDA reconciled to our net loss, the closest GAAP measure, for the periods indicated:
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(in thousands) |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Net loss |
$ |
(12,003 |
) |
$ |
(32,666 |
) |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
||||
Adjusted for: |
||||||||||||||||
Loss on partial debt extinguishment (1) |
- |
3,168 |
1,928 |
3,168 |
||||||||||||
Depreciation and amortization (2) |
7,967 |
9,763 |
18,756 |
31,395 |
||||||||||||
Amortization of capitalized cloud computing implementation costs |
37 |
41 |
112 |
122 |
||||||||||||
Amortization of content assets |
3,873 |
5,467 |
12,525 |
16,487 |
||||||||||||
Interest expense |
1,646 |
2,074 |
5,173 |
6,773 |
||||||||||||
Income tax provision |
115 |
63 |
244 |
99 |
||||||||||||
Equity-based compensation (3) |
3,591 |
6,436 |
12,695 |
19,152 |
||||||||||||
Employee incentives, expected to be settled in equity (4) |
- |
- |
- |
(5,466 |
) |
|||||||||||
Pivot restructuring (5) |
6,531 |
- |
6,531 |
- |
||||||||||||
Restructuring and platform consolidation costs (6) |
- |
1,270 |
1,644 |
7,222 |
||||||||||||
Change in fair value of warrant liabilities |
(1,410 |
) |
(1,072 |
) |
(1,333 |
) |
(1,504 |
) |
||||||||
Gain on sale of property and equipment |
- |
- |
(784 |
) |
- |
|||||||||||
Non-operating (7) |
(211 |
) |
(377 |
) |
(789 |
) |
(1,340 |
) |
||||||||
Adjusted EBITDA |
$ |
10,136 |
$ |
(5,833 |
) |
$ |
19,618 |
$ |
(11,494 |
) |
Results of Operations
The Company has one operating segment. The following discussion of our results and operations is on a consolidated basis.
(in thousands) |
Three months ended September 30, |
Nine months ended September 30, |
||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenue: |
||||||||||||||||
Digital |
$ |
53,702 |
$ |
64,339 |
$ |
173,979 |
$ |
194,326 |
||||||||
Nutrition and other |
47,416 |
58,981 |
153,029 |
197,729 |
||||||||||||
Connected fitness |
1,075 |
4,930 |
5,414 |
16,044 |
||||||||||||
Total revenue |
102,193 |
128,250 |
332,422 |
408,099 |
||||||||||||
Cost of revenue: |
||||||||||||||||
Digital |
10,451 |
16,429 |
34,789 |
47,732 |
||||||||||||
Nutrition and other |
19,653 |
26,699 |
61,558 |
84,940 |
||||||||||||
Connected fitness |
3,278 |
10,091 |
9,606 |
26,312 |
||||||||||||
Total cost of revenue |
33,382 |
53,219 |
105,953 |
158,984 |
||||||||||||
Gross profit |
68,811 |
75,031 |
226,469 |
249,115 |
||||||||||||
Operating expenses: |
||||||||||||||||
Selling and marketing |
45,592 |
69,127 |
161,161 |
222,195 |
||||||||||||
Enterprise technology and development |
19,382 |
18,879 |
54,261 |
56,625 |
||||||||||||
General and administrative |
11,760 |
14,759 |
37,631 |
44,362 |
||||||||||||
Restructuring |
5,087 |
1,270 |
6,731 |
6,550 |
||||||||||||
Total operating expenses |
81,821 |
104,035 |
259,784 |
329,732 |
||||||||||||
Operating loss |
(13,010 |
) |
(29,004 |
) |
(33,315 |
) |
(80,617 |
) |
||||||||
Other income (expense) |
||||||||||||||||
Loss on partial debt extinguishment |
- |
(3,168 |
) |
(1,928 |
) |
(3,168 |
) |
|||||||||
Change in fair value of warrant liabilities |
1,410 |
1,072 |
1,333 |
1,504 |
||||||||||||
Interest expense |
(1,646 |
) |
(2,074 |
) |
(5,173 |
) |
(6,773 |
) |
||||||||
Other income, net |
1,358 |
571 |
2,243 |
1,551 |
||||||||||||
Loss before income taxes |
(11,888 |
) |
(32,603 |
) |
(36,840 |
) |
(87,503 |
) |
||||||||
Income tax provision |
(115 |
) |
(63 |
) |
(244 |
) |
(99 |
) |
||||||||
Net loss |
$ |
(12,003 |
) |
$ |
(32,666 |
) |
$ |
(37,084 |
) |
$ |
(87,602 |
) |
Revenue
Revenue includes digital subscriptions, digital program sales, nutritional supplement subscriptions, one-time nutritional sales, connected fitness products, access to our online Partner business management platform, preferred customer program memberships, and other fitness-related products. We often sell bundled products that combine digital subscriptions, nutritional products, and/or other fitness products. We consider these sales to be revenue arrangements with multiple performance obligations and allocate the transaction price to each performance obligation based on its relative stand-alone selling price. We defer revenue when we receive payments in advance of delivery of products or the performance of services. Digital subscription revenue is recognized ratably over the subscription period of up to 38 months.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Revenue |
||||||||||||||||
Digital |
$ |
53,702 |
$ |
64,339 |
$ |
(10,637 |
) |
(17 |
%) |
|||||||
Nutrition and other |
47,416 |
58,981 |
(11,565 |
) |
(20 |
%) |
||||||||||
Connected fitness |
1,075 |
4,930 |
(3,855 |
) |
(78 |
%) |
||||||||||
Total revenue |
$ |
102,193 |
$ |
128,250 |
$ |
(26,057 |
) |
(20 |
%) |
The decrease in digital revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily attributable to a $9.6 million decrease in revenue from our digital streaming services due to 20% fewer subscriptions on lower demand partially offset by the transition of all digital subscriptions to the higher priced BODi subscription over the past year, a decrease of $0.8 million in fees from Partners as there was a 27% decrease in the number of Partners and a decrease in digital program sales of $0.4 million. With the Pivot and the transition from an MLM model to an affiliate model, the Company will no longer receive fees from Partners beginning as of November 1, 2024. The Company recorded $2.7 million and $8.6 million of fees from Partners for the three and nine months ended September 30, 2024, respectively.
The decrease in nutrition and other revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily attributable to a $9.4 million decrease in revenue from nutritional products due to 27% fewer nutritional subscriptions on lower demand and a $1.6 million decrease in revenue generated from our preferred customer fees as there was a 28% decrease in preferred customers. With the Pivot and the transition from an MLM model to an affiliate model, the Company will no longer receive preferred customer fees beginning as of November 1, 2024. The Company recorded $3.9 million and $12.4 million of preferred customer fees for the three and nine months ended September 30, 2024, respectively. With the Pivot, the Company will also significantly reduce the number and length of events, which will significantly reduce event ticket sales in 2025. The Company recorded zero and $2.6 million of ticket sales for the three and nine months ended September 30, 2024, respectively.
The decrease in connected fitness revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to an approximate 80% decrease in number of bikes delivered from approximately 6,500 for the three months ended September 30, 2023 to approximately 1,300 for the three months ended September 30, 2024 which was partially offset by an approximate 14% increase in the average sales price for a bike. In the three months ended September 30, 2024, management of the Company determined that it would no longer sell connected fitness inventory after December 31, 2024.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Revenue |
||||||||||||||||
Digital |
$ |
173,979 |
$ |
194,326 |
$ |
(20,347 |
) |
(10 |
%) |
|||||||
Nutrition and other |
153,029 |
197,729 |
(44,700 |
) |
(23 |
%) |
||||||||||
Connected fitness |
5,414 |
16,044 |
(10,630 |
) |
(66 |
%) |
||||||||||
Total revenue |
$ |
332,422 |
$ |
408,099 |
$ |
(75,677 |
) |
(19 |
%) |
The decrease in digital revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily attributable to a $19.9 million decrease in revenue from our digital streaming services due to 20% fewer subscriptions on lower demand partially offset by the transition of all digital subscriptions to the higher priced BODi subscription over the past year and a decrease of $1.9 million in fees from Partners due to a 27% decrease in the number of Partners.
The decrease in nutrition and other revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily attributable to a $34.2 million decrease in revenue from nutritional products due to 27% fewer nutritional subscriptions on lower demand, a $6.3 million decrease in revenue generated from our preferred customer fees as there was
a 28% decrease in preferred customers, a $2.2 million decrease in event ticket sales due primarily to the decrease in the number of, length of and attendance at events and a $2.0 million decrease in fitness accessories revenue.
The decrease in connected fitness revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily due to an approximate 62% decrease in the number of bikes delivered from approximately 16,700 for the nine months ended September 30, 2023 to approximately 6,300 for the nine months ended September 30, 2024 and an approximate 11% decrease in the average sales price for a bike.
Cost of Revenue
Digital Cost of Revenue
Digital cost of revenue includes costs associated with digital content creation including amortization and revision of content assets, depreciation of streaming platforms and digital streaming costs. It also includes customer service costs, payment processing fees, depreciation of production equipment, live trainer costs, facilities, and related personnel expenses.
Nutrition and Other Cost of Revenue
Nutrition and other cost of revenue includes product costs, shipping and handling, fulfillment and warehousing, customer service, and payment processing fees. It also includes depreciation of nutrition-related e-commerce websites and social commerce platforms, amortization of acquired formulae intangible assets (in the 2023 period), facilities, and related personnel expenses.
Connected Fitness Cost of Revenue
Connected fitness cost of revenue consists of product costs, including bike and tablet hardware costs, duties and other applicable importing costs, shipping, fulfillment, warehousing and logistics costs, costs associated with service calls and repairs of products under warranty, payment processing and financing fees, customer service expenses, and personnel-related expenses associated with supply chain and logistics.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Cost of revenue |
||||||||||||||||
Digital |
$ |
10,451 |
$ |
16,429 |
$ |
(5,978 |
) |
(36 |
%) |
|||||||
Nutrition and other |
19,653 |
26,699 |
(7,046 |
) |
(26 |
%) |
||||||||||
Connected fitness |
3,278 |
10,091 |
(6,813 |
) |
(68 |
%) |
||||||||||
Total cost of revenue |
$ |
33,382 |
$ |
53,219 |
$ |
(19,837 |
) |
(37 |
%) |
|||||||
Gross profit |
||||||||||||||||
Digital |
$ |
43,251 |
$ |
47,910 |
$ |
(4,659 |
) |
(10 |
%) |
|||||||
Nutrition and other |
27,763 |
32,282 |
(4,519 |
) |
(14 |
%) |
||||||||||
Connected fitness |
(2,203 |
) |
(5,161 |
) |
2,958 |
57 |
% |
|||||||||
Total gross profit |
$ |
68,811 |
$ |
75,031 |
$ |
(6,220 |
) |
(8 |
%) |
|||||||
Gross margin |
||||||||||||||||
Digital |
80.5 |
% |
74.5 |
% |
||||||||||||
Nutrition and other |
58.6 |
% |
54.7 |
% |
||||||||||||
Connected fitness |
(204.9 |
%) |
(104.7 |
%) |
||||||||||||
Total gross margin |
67.3 |
% |
58.5 |
% |
The decrease in digital cost of revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to a $1.7 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets, a $1.6 million decrease in the amortization of content assets as the result of lower production spend and a $1.4 million decrease in digital content revisions. The increase in digital gross margin for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 was primarily as a result of the decrease in expenses as noted above.
The decrease in nutrition and other cost of revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to a $3.0 million decrease in product costs and a $1.8 million decrease in fulfillment, freight and shipping expenses related to the decrease in nutrition and other revenue, a $0.8 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets and a $0.4 million decrease in customer service expense due to a decrease in
the volume of contacts related to nutrition and other revenue. The increase in nutrition and other gross margin for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 was primarily as a result of a decrease in inventory adjustments and a decrease in depreciation expense.
The decrease in connected fitness cost of revenue for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was driven by a $2.7 million decrease in freight, fulfillment and shipping expenses and a $1.4 million decrease in product costs, as the result of an approximate 80% decrease in the number of bikes delivered, and lower inventory adjustments of $2.2 million. The decrease in connected fitness gross margin for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 was primarily as a result of fixed expenses on lower connected fitness revenue.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Cost of revenue |
||||||||||||||||
Digital |
$ |
34,789 |
$ |
47,732 |
$ |
(12,943 |
) |
(27 |
%) |
|||||||
Nutrition and other |
61,558 |
84,940 |
(23,382 |
) |
(28 |
%) |
||||||||||
Connected fitness |
9,606 |
26,312 |
(16,706 |
) |
(63 |
%) |
||||||||||
Total cost of revenue |
$ |
105,953 |
$ |
158,984 |
$ |
(53,031 |
) |
(33 |
%) |
|||||||
Gross profit |
||||||||||||||||
Digital |
$ |
139,190 |
$ |
146,594 |
$ |
(7,404 |
) |
(5 |
%) |
|||||||
Nutrition and other |
91,471 |
112,789 |
(21,318 |
) |
(19 |
%) |
||||||||||
Connected fitness |
(4,192 |
) |
(10,268 |
) |
6,076 |
59 |
% |
|||||||||
Total gross profit |
$ |
226,469 |
$ |
249,115 |
$ |
(22,646 |
) |
(9 |
%) |
|||||||
Gross margin |
||||||||||||||||
Digital |
80.0 |
% |
75.4 |
% |
||||||||||||
Nutrition and other |
59.8 |
% |
57.0 |
% |
||||||||||||
Connected fitness |
(77.4 |
%) |
(64.0 |
%) |
||||||||||||
Total gross margin |
68.1 |
% |
61.0 |
% |
The decrease in digital cost of revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was due to a $4.7 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets, a $4.0 million decrease in digital content amortization as a result of lower production spend and a $2.8 million decrease in digital content revisions. The increase in digital gross margin for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 was primarily as a result of the decrease in expenses as noted above.
The decrease in nutrition and other cost of revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily due to a $7.9 million decrease in product costs and a $5.8 million decrease in fulfillment, freight and shipping expenses related to the decrease in nutrition and other revenue, a $3.7 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets, a $2.1 million decrease in customer service expense due to a decrease in the volume of contacts related to nutrition and other revenue and lower inventory adjustments of $2.0 million. Nutrition and other gross margin increased for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 primarily as a result of the decrease in depreciation expense and a decrease in inventory adjustments.
The decrease in connected fitness cost of revenue for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was driven by a $5.6 million decrease in product costs and a $5.1 million decrease in freight, fulfillment, and shipping expenses, as the result of an approximate 62% decrease in the number of bikes delivered and lower inventory adjustments of $4.6 million. The decrease in connected fitness gross margin for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 was due primarily to fixed expenses on lower connected fitness revenue.
Operating Expenses
Selling and Marketing
Selling and marketing expenses primarily include the cost of Partner compensation, advertising, royalties, promotions and events, and third-party sales commissions as well as the personnel expenses for employees and consultants who support these areas. Selling and marketing expense as a percentage of total revenue may fluctuate from period to period based on total revenue, timing of new content and nutritional product launches, and the timing of our media investments to build awareness around launch activity.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Selling and marketing |
$ |
45,592 |
$ |
69,127 |
$ |
(23,535 |
) |
(34 |
%) |
|||||||
As a percentage of total revenue |
44.6 |
% |
53.9 |
% |
The decrease in selling and marketing expense for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to a $12.2 million decrease in Partner compensation as a result of the decrease in the number of Partners, lower commissionable revenue and a decrease in the commission rate paid to Partners that started at the beginning of January 2024, a $3.2 million decrease in media expenses due to management's focus on reducing expense, a $3.1 million decrease in personnel-related expenses due to lower headcount primarily related to the non-Pivot related restructuring activities that occurred in the past year and the modification of certain stock awards for employees who were impacted by the Pivot, a $2.1 million decrease in event expenses due primarily to no events in the three months ended September 30, 2024, and a $1.1 million decrease in the amortization of intangible assets due to the impairment of the remaining intangible asset balance in the fourth quarter of 2023. With the Pivot and the transition from the MLM model to an affiliate model, the Company will significantly reduce the number and length of events for Partners and these event expenses are expected to be reduced significantly in 2025. The Company recorded approximately zero and $5.5 million of event expenses for the three and nine months ended September 30, 2024, respectively. The Company also expects a decrease in personnel-related expenses due to the headcount reductions associated with the Pivot.
Selling and marketing expense as a percentage of total revenue decreased by 930 basis points ("bps") primarily due to the decrease in Partner compensation, media expenses and event expenses.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Selling and marketing |
$ |
161,161 |
$ |
222,195 |
$ |
(61,034 |
) |
(27 |
%) |
|||||||
As a percentage of total revenue |
48.5 |
% |
54.4 |
% |
The decrease in selling and marketing expense for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily due to a $35.1 million decrease in Partner compensation as a result of the decrease in the number of Partners, lower commissionable revenue and a decrease in the commission rate paid to Partners that started at the beginning of January 2024, a $10.4 million decrease in event expenses due primarily to a decrease in the number of, length of and attendance at events, a $5.8 million decrease in personnel-related expenses due to lower headcount primarily related to the non-Pivot related restructuring activities that occurred in the past year and due to the modification of certain stock awards for employees who were impacted by the Pivot, a $3.4 million decrease in the amortization of intangible assets due to the impairment of the remaining intangible asset balance in the fourth quarter of 2023 and a $2.4 million decrease in media expenses due to management's focus on reducing expense.
Selling and marketing expense as a percentage of total revenue decreased by 590 bps primarily due to the decrease in Partner compensation and event expenses.
Enterprise Technology and Development
Enterprise technology and development expenses includes maintenance and enhancements of the Company's enterprise resource planning system, which is the core of our accounting, procurement, supply chain and other business support systems and primarily relate to enterprise systems applications, hardware, and software that serve as the technology infrastructure for the Company and are not directly related to services provided or tangible goods sold. Enterprise technology and development expenses also includes reporting and business analytics tools, security systems such as identity management and payment card industry compliance, office productivity software, research and development tracking tools, and other non-customer facing applications. Enterprise technology and development expenses include personnel-related expenses for employees and consultants to maintain technology systems and are involved in the research and development of new and existing nutritional products, depreciation of enterprise technology-related assets, software licenses, hosting expenses, and technology equipment leases.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Enterprise technology and development |
$ |
19,382 |
$ |
18,879 |
$ |
503 |
3 |
% |
||||||||
As a percentage of total revenue |
19.0 |
% |
14.7 |
% |
The increase in enterprise technology and development expenses for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to a $2.0 million increase in depreciation expense as a result of accelerated depreciation of $2.9 million recorded related to certain long-lived assets that due to the Pivot will no longer be used by the Company after December 31, 2024 partially offset by a $1.3 million decrease in personnel-related expenses due to lower headcount primarily related to the non-Pivot related restructuring activities that occurred in the past year. With the Pivot and the transition from the MLM model to an affiliate model, the Company expects a decrease in personnel-related expenses in 2025, due to the headcount reductions associated with the Pivot, and a significant decrease in depreciation expense in 2025 due to the long-lived assets impacted by Pivot which will be fully depreciated by December 31, 2024.
Enterprise technology and development expense as a percentage of total revenue increased by 430 bps due to the accelerated depreciation on the long-lived assets impacted by the Pivot, as well as a decrease in revenue at a faster pace than the reduction in enterprise technology and development expenses.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Enterprise technology and development |
$ |
54,261 |
$ |
56,625 |
$ |
(2,364 |
) |
(4 |
%) |
|||||||
As a percentage of total revenue |
16.3 |
% |
13.9 |
% |
The decrease in enterprise technology and development expenses for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily due to a $1.6 million decrease in personnel-related expenses due to lower headcount primarily related to the non-Pivot related restructuring activities that occurred in the past year and a $0.4 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets, which was partially offset by accelerated depreciation of $2.9 million recorded related to certain long-lived assets that due to the Pivot will no longer be used by the Company after December 31, 2024.
Enterprise technology and development expense as a percentage of total revenue increased by 240 bps due to the accelerated depreciation on the long-lived assets impacted by the Pivot, as well as a decrease in revenue at a faster pace than the reduction in enterprise technology and development expenses.
General and Administrative
General and administrative expenses includes personnel-related expenses and facilities-related costs primarily for our executive, finance, accounting, legal and human resources functions. General and administrative expenses also includes fees for professional services principally comprised of legal, audit, tax, and insurance.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
General and administrative |
$ |
11,760 |
$ |
14,759 |
$ |
(2,999 |
) |
(20 |
%) |
|||||||
As a percentage of total revenue |
11.5 |
% |
11.5 |
% |
The decrease in general and administrative expenses for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily due to a $1.5 million decrease in professional and accounting fees due to a management focus on decreasing spending and a decrease in equity based compensation of $1.0 million due primarily to the decrease in headcount and the modification of certain stock awards for employees who were impacted by the Pivot.
General and administrative expenses as a percentage of total revenue was unchanged from the prior year.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
General and administrative |
$ |
37,631 |
$ |
44,362 |
$ |
(6,731 |
) |
(15 |
%) |
|||||||
As a percentage of total revenue |
11.3 |
% |
10.9 |
% |
The decrease in general and administrative expenses for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily due to a $3.8 million decrease in professional and accounting fees due to a management focus on decreasing spending, a $1.7 million decrease in insurance expense as some of our insurance is based on the level of the Company's revenues or the number of employees, which both have declined in the current period compared to the prior period, a decrease in equity based compensation of $1.6 million due primarily to the decrease in headcount and the modification of certain stock awards for employees who were impacted by the Pivot, and a $0.8 million gain on the sale of the Van Nuys facility which was recorded as a reduction of general and administrative expenses in the three months ended March 31, 2024.
General and administrative expense as a percentage of total revenue increased by 40 bps due to the decrease in revenue at a faster pace than the reduction in general and administrative expenses.
Restructuring
In 2024, restructuring charges primarily relate to the Pivot which was announced by the Company on September 30, 2024 (see Note 12, Restructuring, for more information on the Pivot) and key initiatives. Restructuring charges in 2023 relate to activities focused on aligning our operations with our key growth priorities, including a reduction in headcount. The charges incurred primarily consist of employee termination costs.
Three months ended September 30, |
||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||
(dollars in thousands) |
||||||||||||||
Restructuring |
$ |
5,087 |
$ |
1,270 |
$ |
3,817 |
NM |
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Restructuring |
$ |
6,731 |
$ |
6,550 |
$ |
181 |
3 |
% |
Other Income (Expense)
The change in fair value of warrant liabilities consists of the fair value changes of the public, private placement, Term Loan And Common Stock warrants. Interest expense primarily consists of interest expense associated with our borrowings and amortization of debt discount and issuance costs for our Term Loan (as defined below). Other income, net, consists of interest income earned on investments and gains (losses) on foreign currency.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Loss on partial debt extinguishment |
$ |
- |
$ |
(3,168 |
) |
$ |
3,168 |
(100 |
%) |
|||||||
Change in fair value of warrant liabilities |
1,410 |
1,072 |
338 |
32 |
% |
|||||||||||
Interest expense |
(1,646 |
) |
(2,074 |
) |
428 |
(21 |
%) |
|||||||||
Other income, net |
1,358 |
571 |
787 |
NM |
The loss on partial debt extinguishment for the three months ended September 30, 2023 was due to the partial prepayment of $15.0 million on the Term Loan as of July 24, 2023. The change in fair value of warrant liabilities during the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, primarily resulted from the decline in our stock price during the current quarter and an increase in the number of outstanding warrants due to the Common Stock Warrants that were issued in December 2023. The decrease in interest expense was primarily due to principal prepayments of $25.5 million on the outstanding Term Loan balance from July 1, 2023 to September 30, 2024. The increase in other income was primarily due to a $1.2 million gain on the sale of a legal claim for a litigation settlement in the current quarter.
Nine months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Loss on partial debt extinguishment |
$ |
(1,928 |
) |
$ |
(3,168 |
) |
$ |
1,240 |
(39 |
%) |
||||||
Change in fair value of warrant liabilities |
1,333 |
1,504 |
(171 |
) |
(11 |
%) |
||||||||||
Interest expense |
(5,173 |
) |
(6,773 |
) |
1,600 |
(24 |
%) |
|||||||||
Other income, net |
2,243 |
1,551 |
692 |
45 |
% |
The change in the loss on partial debt extinguishment for the nine months ended September 30, 2024 was due to partial prepayments of $10.5 million on the Term Loan that occurred in the nine months ended September 30, 2024 as compared to partial prepayments of $15.0 million in the nine months ended September 30, 2023. The change in fair value of warrant liabilities during the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, primarily resulted from a lower decrease in our stock price during the current period as compared to the decrease in our stock price in the prior year period. The decrease in interest expense was primarily due to principal prepayments of $25.5 million on the outstanding Term Loan balance from July 1, 2023 to September 30, 2024. The increase in other income was primarily due to a $1.2 million gain on the sale of a legal claim for a litigation settlement in the quarter ended September 30, 2024.
Income Tax Provision
Income tax provision consists of income taxes related to U.S. federal and state jurisdictions as well as those foreign jurisdictions where we have business operations.
Three months ended September 30, |
||||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||||
(dollars in thousands) |
||||||||||||||||
Income tax provision |
$ |
(115 |
) |
$ |
(63 |
) |
$ |
(52 |
) |
83 |
% |
The income tax provision increase for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, was primarily driven by changes in our valuation allowance and an increase in the net expense from discrete events.
Nine months ended September 30, |
||||||||||||||
2024 |
2023 |
$ Change |
% Change |
|||||||||||
(dollars in thousands) |
||||||||||||||
Income tax provision |
$ |
(244 |
) |
$ |
(99 |
) |
$ |
(145 |
) |
NM |
The income tax provision increase for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, was primarily driven by changes in our valuation allowance and an increase in the net expense from discrete events.
Liquidity and Capital Resources
Nine months ended September 30, |
||||||||
2024 |
2023 |
|||||||
(in thousands) |
||||||||
Net cash provided by (used in) operating activities |
$ |
9,291 |
$ |
(14,583 |
) |
|||
Net cash provided by (used in) investing activities |
1,626 |
(9,749 |
) |
|||||
Net cash used in financing activities |
(11,810 |
) |
(17,727 |
) |
As of September 30, 2024, we had cash and cash equivalents totaling $32.3 million.
Net cash provided by (used in) operating activities was $9.3 million and $(14.6) million for the nine months ended September 30, 2024 and 2023, respectively. The increase in net cash provided by operating activities during the nine months ended September 30, 2024, compared to the prior year period, was primarily due to a decrease in net loss of $50.5 million, an increase in cash provided by other assets of $15.7 million and a decrease in cash used for accrued expenses of $12.0 million partially offset by a decrease in cash provided by deferred revenue of $13.3 million, a decrease in depreciation and amortization expense of $12.6 million, a decrease in cash provided by inventory of $7.7 million, a decrease in provision for inventory and inventory purchase commitments of $6.6 million, a decrease in cash provided by equity based compensation of $6.5 million and in increase in cash used in other liabilities of $4.2 million.
Net cash provided by (used in) investing activities was $1.6 million and $(9.7) million for the nine months ended September 30, 2024 and 2023, respectively. The increase in net cash provided by investing activities was due to proceeds received from the sale of the Van Nuys facility of $5.6 million and a decrease in capital expenditures of $1.5 million due to increased focus by management on capital expenditures, in particular related to technology.
Net cash used in financing activities was $11.8 million and $17.7 million for the nine months ended September 30, 2024 and 2023, respectively. The decrease in net cash used in financing activities was primarily due to a decrease in debt repayments on our Term Loan in the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023.
On August 8, 2022, the Company, Beachbody, LLC, a Delaware limited liability company and wholly-owned direct subsidiary of the Company (the "Borrower"), and certain subsidiaries of the Company (together with the Company, the "Guarantors"), entered into a financing agreement (as amended, the "Financing Agreement") with the lenders party thereto and Blue Torch Finance, LLC, ("Blue Torch") as administrative agent and collateral agent for such lenders, providing for a senior secured term loan facility in an initial aggregate principal amount of $50.0 million (the "Term Loan"). Obligations under the Financing Agreement are guaranteed by the Guarantors, and secured by a lien on and security interest in substantially all of the assets of the Borrower and the Guarantors (together with the Borrower, the "Loan Parties"), subject to customary exceptions. On July 24, 2023, the Company and Blue Torch entered into the Second Amendment. In connection with the Second Amendment, on the Second Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $15.0 million. On January 9, 2024, February 29, 2024 and April 5, 2024, the Company made partial prepayments of $1.0 million, $5.5 million and $4.0 million, respectively, on the Term Loan in connection with the Third, Fourth and Fifth Amendments. As of September 30, 2024, the principal balance outstanding (including capitalized paid in kind interest) under the Term Loan was $25.3 million. On October 18, 2024, the Company and Blue Torch entered into the Sixth Amendment. In connection with the Sixth Amendment, on the Sixth Amendment Effective Date, the Company made partial prepayments on the Term Loan of $3.2 million (which was classified as a current obligation at September 30, 2024). During the nine months ended September 30, 2024, the Term Loan was a secured overnight financing rate ("SOFR") loan, with an effective interest rate of 23.35% and a cash interest rate of 12.77% for the nine months ended September 30, 2024.
The Financing Agreement contains financial covenants, customary representations, warranties, covenants and customary events of default. In particular, the Financing Agreement contains a minimum liquidity financial covenant of $18.0 million as of September 30, 2024, which was amended in the Sixth Amendment to (a) $9.5 million from the Sixth Amendment Effective Date through December 31, 2024 and (b) $13.0 million from January 1, 2025 to the maturity of the Term Loan. We were in compliance with the financial covenants as of September 30, 2024. See Note 15, Subsequent Events, for additional information on the amendments to the Term Loan including amendments to the financial covenants. We expect to remain in compliance with the amended financial covenants based on our current expectation of future results of operations. Unexpected weakness in the demand for our products may interfere with our ability to remain in compliance with the amended covenants, in particular the minimum liquidity financial covenant for which the cushion in passing is expected to narrow in upcoming quarters. Failure to comply with the financial and other covenants under the Financing Agreement, would constitute a condition of default and would allow Blue Torch to accelerate the maturity of all indebtedness
under the Financing Agreement. If such acceleration were to occur, we would likely have to seek an amendment and/or waiver of the impacted financial covenant or repay the debt with proceeds from the issuance of new debt or equity, or asset sales, if necessary. We may be unable to amend the Financing Agreement or raise sufficient capital to repay such obligations in the event the maturity is accelerated. See Note 9, Debt, and Note 15, Subsequent Events, for additional information on the Term Loan.
As of September 30, 2024, we have $19.2 million of lease obligations and purchase commitments associated with contracts that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions, and the approximate timing of the actions under the contracts. See Note 8, Commitments and Contingencies, for discussion of our contractual commitments that are primarily due within the next year.
Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth and overall economic conditions. We continue to assess and efficiently manage our working capital and expect to generate additional liquidity through continued cost control initiatives. We believe that existing cash and cash equivalents and cost control initiatives will provide the Company with sufficient liquidity to meet our anticipated cash needs, including debt service requirements, for the next twelve months as well as for the longer-term (i.e., beyond the next twelve months).
We may explore additional debt or equity financing to supplement our anticipated working capital balances and further strengthen our financial position, but do not at this time know which form it will take or what the terms will be. The incurrence of additional debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financial covenants that would restrict our operations. The sale of additional equity would result in additional dilution to our shareholders. There can be no assurances that we will be able to raise additional capital in amounts or on terms acceptable to us.
Critical Accounting Policies and Estimates
There have been no material changes to the Company's critical accounting policies and estimates discussed in the 2023 Annual Report on Form 10-K in Item 7 under the heading Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates other than noted below.
Goodwill and Long-Lived Assets Impairment
Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually at December 31 and between annual tests if an event or change in circumstances occurs that would more likely than not reduce the fair value of a reporting unit ("RU") below its carrying value or indicate that it is more likely than not that an indefinite-lived intangible asset is impaired. We carry our definite-lived intangible assets at cost less accumulated amortization. If an event or change in circumstances occurs that indicates the carrying value may not be recoverable, we would evaluate our definite-lived intangible assets for impairment at that time.
We test goodwill for impairment at a level within the Company referred to as the RU. Due to the continued sustained decline in our market capitalization in the three and nine months ended September 30, 2024 and the impact of the Pivot, which was approved by the Board of Directors of the Company in late September 2024, the Company performed an interim test for impairment of its goodwill as of September 30, 2024.
In performing the interim impairment test for goodwill, the Company elected to bypass the optional qualitative assessment test and proceeded to perform a quantitative test by comparing the carrying value of its RU to its estimated fair value. The Company previously tested its RU for impairment as of December 31, 2023. Fair value is estimated using a combination of a market approach and an income approach, with significant assumptions related to guideline company financial multiples used in the market approach and significant assumptions about revenue growth, long-term growth rates and discount rates used in a discounted cash flow model in the income approach. The estimates used to determine fair value for the RU may change based on the results of operations, macro-economic conditions, stock price fluctuations or other factors. Changes in these estimates could materially affect our assessment of the fair value and goodwill impairment for the RU. As of September 30, 2024, management concluded that the fair value of its RU exceeded its carrying value by approximately 10%, or $5.6 million, resulting in no impairment. It is possible that our goodwill could become impaired if we determine in a subsequent period that the fair value of our RU was less than its carrying value which could result in a material charge and adversely affect our results of operations.
Due to reduced revenue and margin forecasts, we tested the related asset group for recoverability as of September 30, 2024. In testing for recoverability, we compared the carrying value of the asset group to its forecasted undiscounted cash flows to determine whether it was recoverable. The Company performed a test for recoverability at September 30, 2024 and concluded that the carrying value of its long-lived assets was recoverable.
Management will continue to monitor its RU and long-lived asset group for changes in the business environment that could impact its fair value. Examples of events or circumstances that could result in changes to the underlying key assumptions and judgments used in our goodwill impairment tests, and ultimately impact the estimated fair value of our RU may include supply chain disruptions and demand for at-home fitness solutions; adverse macroeconomic conditions; volatility in the equity and debt markets which could result in higher weighted-average cost of capital and our subscriber growth rates. Changes in any of the assumptions used in the valuation of the RU, or changes in the business environment could materially affect the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge.
Recent Accounting Pronouncements
See Note 1, Description of Business and Summary of Significant Accounting Policies, of the notes to our unaudited condensed consolidated financial statements included elsewhere in this Report for recently adopted accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Foreign Currency Risk
We are exposed to foreign currency exchange risk related to transactions in currencies other than the U.S. Dollar, which is our functional currency. Our foreign subsidiaries, sales, certain inventory purchases and operating expenses expose us to foreign currency exchange risk. For the nine months ended September 30, 2024 and 2023, approximately 10% of our revenue was in foreign currencies. These sales were primarily denominated in Canadian dollars and British pounds.
We may use derivative instruments to manage the effects of fluctuations in foreign currency exchange rates on our net cash flows. We primarily enter into option contracts to hedge forecasted payments, typically for up to 12 months, for cost of revenue, selling and marketing expenses, general and administrative expenses and intercompany transactions not denominated in the local currencies of our foreign operations. We designate some of these instruments as cash flow hedges and record them at fair value as either assets or liabilities within the consolidated balance sheets. Some of these instruments are freestanding derivatives for which hedge accounting does not apply.
In the year ended December 31, 2023, management made a determination to cease entering into any further foreign exchange options at this time, which resulted in a decrease in the notional amount of the Company's outstanding foreign exchange options to zero at September 30, 2024 as all of the foreign exchange options expired prior to March 31, 2024. As part of the Pivot, the Company has decided to exit the sale of nutritional and other physical products in the United Kingdom (the "UK") and France. Nutrition and other revenue in the UK and France is not significant.
Changes in the fair value of cash flow hedges are recorded in accumulated other comprehensive income (loss) until the hedged forecasted transaction affects earnings. Deferred gains and losses associated with cash flow hedges of third-party payments are recognized in cost of revenue, selling and marketing or general and administrative expenses, as applicable, during the period when the hedged underlying transaction affects earnings. Changes in the fair value of certain derivatives for which hedge accounting does not apply are immediately recognized directly in earnings to cost of revenue.
A hypothetical 10% change in exchange rates, with the U.S. dollar as the functional and reporting currency, would result in an approximate $2.8 million increase or decrease in cost of revenue and operating expenses. The higher exposure to changes in foreign currency from previous periods was due to management's decision to cease entering into foreign exchange options at this time.
The aggregate notional amount of foreign exchange derivative instruments at September 30, 2024 and year ended December 31, 2023 was zero and $4.4 million, respectively.
Item 4. Controls and Procedures.
Management's Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer and Interim Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of September 30, 2024. Based upon that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Report.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, as specified above. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met.
PART II-OTHER INFORMATION
Item 1. Legal Proceedings.
We are and, from time to time, we may become, involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Other than as set forth below, there have been no material changes from the information previously reported under Part I, Item 3 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
On May 22, 2023, Jessica Lyons, an individual, and a group of other plaintiffs filed a class action complaint with the Los Angeles County Superior Court alleging that the Company misclassified its Partners as contractors rather than as employees and committed other violations of the California Labor Code. The Company understands that the plaintiffs in this matter intend on filing additional claims under the Private Attorney General Act of 2004. The Company and certain executive officers are listed as defendants in the complaint. The plaintiffs are seeking monetary damages. The Company filed a motion to compel arbitration in the case. The firm representing Ms. Lyons has also filed 13 arbitration actions in Los Angeles County in anticipation that the Company's motion to compel arbitration will be upheld. All arbitration proceedings have been stayed pending the outcome of the mediation and follow-up discussions. This matter is pending as of the date of this quarterly report. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
On September 6, 2023 Dish Technologies LLC and SLING TV LLC (the "DISH Entities") filed a complaint with the United States District Court for the District of Delaware alleging that the Company infringed on the DISH Entities' patents and used technology belonging to the DISH Entities without their permission. The plaintiffs are seeking monetary damages and injunctive relief. In an effort to avoid any further unnecessary litigation costs, the parties entered into a Confidential Standstill and Tolling Agreement as of April 16, 2024 which included a dismissal of the case by the DISH Entities without prejudice and an agreement by the DISH Entities not to institute any litigation proceedings against the Company under the patents any earlier than December 31, 2026 in exchange for a one-time immaterial payment to the DISH Entities by the Company.
On June 14, 2024, Bryan Reilly on behalf of himself and similarly situated current and former stockholders of Forest Road Acquisition Corp., which later became the Beachbody Company, Inc. ("Forest Road"), filed a verified class action complaint (the "Reilly Action") against the former directors and officers of Forest Road, as well as Forest Road Acquisition Sponsor LLC, Forest Road Company LLC, Zach Tarica, and Jeremy Tarica (together the "Forest Road Sponsor Defendants") alleging claims for breach of fiduciary duty in connection with the merger among Forest Road, The Beachbody Company, Inc., and Myx in 2021 (the "Merger"). The lawsuit also brought claims against the Company, Kevin Meyer, and The Raine Group LLC ("Raine") alleging aiding and abetting breach of fiduciary duty, and against the former Forest Road directors and officers, the Forest Road Sponsor Defendants, Raine, and Meyer for unjust enrichment. We also have certain indemnification obligations as to some or all of the former Forest Road directors and Raine as to certain claims.
The Reilly Action generally alleges that the proxy that Forest Road issued prior to the Merger contained numerous material misstatements and omissions that impaired the Forest Road stockholders' ability to make an informed decision regarding whether to redeem their stock in connection with the Merger. The plaintiff also asserts that the Merger was a conflicted transaction because the Forest Road Sponsor Defendants and the former Forest Road directors were incentivized to close the Merger even if it was a value-decreasing transaction for Forest Road's public stockholders. As to the Company, Meyer, and Raine, the complaint alleges that these defendants aided and abetted the Forest Road defendants' disclosure violations. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
On October 14, 2024, the firm Milberg Coleman Bryson Phillips Grossman ("Milberg") filed 10 arbitration demands alleging that the Company violated the Video Privacy Protection Act. The arbitration demands state that Milberg currently represents approximately 6,239 additional subscribers of BODi and intends to file similar demands for each person. the plaintiffs are seeking monetary damages as well as injunctive and equitable relief. We deny the allegations in the complaint, believe they are without merit, and intend to vigorously defend ourselves in this action.
Item 1A. Risk Factors.
There have been no material developments with respect to the information previously reported under Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 other than as noted below. These risk factors describe some of the assumptions, risks, uncertainties and other factors that could adversely affect our business or that could otherwise result in changes that differ materially from our expectations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
On September 30, 2024, we announced strategic initiatives to transition from our Multi-Level Marketing ("MLM") model to a single level affiliate model (the "Pivot"). As part of the Pivot, we will continue to execute an omni channel selling strategy including direct response marketing, retail partnerships and transition our direct selling channel from our current MLM model to a new business model focused on a single level affiliate model.
The announced Pivot involves numerous risks, including, but not limited to:
If any of these or other factors impair our ability to successfully implement the Pivot, we may not be able to realize other business opportunities as we may be required to spend additional time and incur additional expenses related to the Pivot that otherwise would be used on the development and expansion of our business.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosure.
Not applicable.
Item 5. Other Information.
During the three months ended September 30, 2024, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," each as defined in Item 408(a) of Regulation S-k.
Item 6. Exhibits.
Exhibit |
Incorporated by Reference |
Filed or Furnished herewith |
||||
Form |
Exhibit |
Filing Date |
File No. |
|||
3.1 |
Second Amended and Restated Certificate of Incorporation of The Beachbody Company, Inc. |
10-K |
3.1 |
3/11/2024 |
001-39735 |
|
3.2 |
Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of The Beachbody Company, Inc. |
8-K |
3.1 |
11/27/2023 |
001-39735 |
|
3.3 |
Amended and Restated Bylaws of The Beachbody Company, Inc. |
8-K |
3.2 |
7/1/2021 |
001-39735 |
|
4.1 |
Form of Third Amended and Restated Warrant to Purchase Stock |
8-K |
10.2 |
10/21/2024 |
001-39735 |
|
10.1 |
Amendment No. 6 to Financing Agreement, dated as of October 18, 2024 by and among the Company, the Borrower, the lenders party thereto and Blue Torch, as collateral agent and as administrative agent |
8-K |
10.1 |
10/21/2024 |
001-39735 |
|
31.1 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) |
* |
||||
31.2 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) |
* |
||||
32.1 |
Certification of Chief Executive Officer and Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350 |
** |
||||
101.INS |
Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
* |
||||
101.SCH |
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
* |
||||
104 |
Cover page formatted as Inline XBRL and contained in Exhibit 101 |
* Filed herewith
** Furnished herewith.
+ Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish copies of any such schedules and exhibits to the SEC upon request.
^ Indicates management contract or compensatory plan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
The Beachbody Company, Inc. |
|||
Date: November 12, 2024 |
By: |
/s/ Carl Daikeler |
|
Carl Daikeler |
|||
Chief Executive Officer |
|||
(Principal Executive Officer) |
|||
Date: November 12, 2024 |
By: |
/s/ Brad Ramberg |
|
Brad Ramberg |
|||
Interim Chief Financial Officer |
|||
(Interim Principal Financial Officer) |
Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Carl Daikeler, certify that:
Date: November 12, 2024 |
By: |
/s/ Carl Daikeler |
|
Carl Daikeler |
|||
Chief Executive Officer (Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Brad Ramberg, certify that:
Date: November 12, 2024 |
By: |
/s/ Brad Ramberg |
|
Brad Ramberg |
|||
Interim Chief Financial Officer (Interim Principal Financial Officer) |
x
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of The Beachbody Company, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: November 12, 2024 |
By: |
/s/ Carl Daikeler |
|
Carl Daikeler |
|||
Chief Executive Officer (Principal Executive Officer) |
In connection with the Quarterly Report of The Beachbody Company, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: November 12, 2024 |
By: |
/s/ Brad Ramberg |
|
Brad Ramberg |
|||
Interim Chief Financial Officer (Interim Principal Financial Officer) |